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Polymeric nano and microparticles are important tools for an increasing variety of 
applications in the life sciences such as cellular delivery, sensing and imaging, with a 
fundamental requirement being particle functionalisation. Herein, the use of zeta 
potential measurements is described as a convenient tool to allow a variety of 
chemical reactions to be rapidly monitored on particles. To allow multi-
functionalisations these particles need to be orthogonally modified. As part of this 
thesis, novel dual-functionalised aminomethyl and boronic acid particles were 
synthesised. These particles could be modified via amide formation and palladium-
mediated cross coupling, with applications demonstrated in cellular delivery and cell-
based cargo release. The requirement for bright fluorescent particles for applications 
in the life sciences was addressed by the synthesis and analysis of particles prepared 
using polymerisable fluorescein derivatives. Although nanoparticles are a promising 
technology to solve a variety of problems, their behaviour in biological systems is 
not fully understood. Herein, the effects of the particle’s surface chemistry on 
cellular uptake and toxicity were investigated. 
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POLYMERIC PARTICLES  
IN THE LIFE SCIENCES 
 
1.1 Nanotechnology 
The European commission considers the progress and developments in the field of 
nanotechnology as paramount for all aspects of life in the European Union, with the 
belief that it will contribute to growth, competitiveness and sustainability of Europe 
and with far reaching implications for its citizens as well as people around the 
world.
1
 A similar approach has been undertaken by a large number of global 
governments including the United Kingdom.
2
 Indeed the market for nanotechnology 
already exists and has done for many years
3
 and is expected to grow up to US$ one 
trillion by 2015.
4
 How is nanotechnology able to evoke so many aspirations?  
Nanotechnology describes the study and development of materials with at least 
one dimension having a size between 1 nm and 100 nm. Materials applying to this 
definition can have unique properties not seen for the same material at larger sizes. 
However, the size boundaries are fluid and materials can show size-related effects at 
larger sizes up to 500 nm.
5
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The electronic properties of molecules have been shown to be influenced by 
molecules in nanosize ranges resulting in previously unknown materials such as 
quantum dots (< 10 nm) which are used in optical imaging.
6
 Furthermore, optical 
properties can also be changed, e.g. nano-sized pigments are transparent and widely 
applied as additives in cosmetics or paint coatings.
7
 Due to the small size of 
nanoparticles they are also extensively used for biological and medicinal applications 
since they are small enough to cross biological barriers and offer novel techniques 
for diagnosis and therapy.
8
  
Probably the most significant property of nanomaterials in contrast to their 
respective bulk materials is their extremely high surface area to volume ratio. The 
surface area grows exponentially with decreasing particle diameter by constant 
volume (Figure 1.1). This effect starts to dominate the properties of spherical 
particles with diameters smaller than approximately 200 nm. The high surface area 
implies also that an exceptional high number of atoms are present on the surface in 
comparison to the bulk resulting in amplification of the surface charges and forces 









Fig. 1.1. Relation between surface area and the diameter of spherical particles with 
constant volume. 
 
The high number of surface atoms makes nanoparticles very reactive
9
 and has 
been used to accelerate heterogeneous catalysed reactions.
10
 Furthermore, novel 
catalysts have been developed, for example gold showed chemoselective catalytic 
activity if smaller than 3 nm,
11
 while iron atoms deposited on silica nanoparticles 
demonstrated selective oxidation of alkenes and arenes.
12
 
However, nanomaterials and its exposure to humans are also of great concern. The 
properties of nanoparticles such as their small size and high reactivity are beneficial 
for a variety of applications but both are associated with an increased risk towards 
human health. Indeed, a number of nanomaterials have been assessed to be toxic 
although the same material in larger sizes was not. Hence, an understanding of the 
toxicological paradigms of nanomaterials is also part of nanotechnology and of 
utmost importance for continuing successful developments in this field.
13
 
The above mentioned properties contribute to the high aspirations of 
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concerning healthcare, the environment and manufacturing processes. The number of 
novel materials prepared in nano-sized dimensions with ever new applications 
continuously increases. For example, nanodiamonds
14
 and carbon dots
15
 were 
developed in the previous decade and hold great promise for applications in the life 
sciences. 
 
1.2 Applications of polymeric particles  
POLYMERIC PARTICLES. Chemical structures consisting of polymers that form 
particulate structures are classified as polymeric particles, e.g. nanocapsules, micelles 
and nanospheres.
16
 Nanocapsules have a characteristic inner compartment able to be 
loaded with a solid or liquid cargo.
17
 Polymeric particles that originate from self-
assembled polymers are known as micelles.
18
 In contrast, nanospheres that form 
relatively rigid structures have been prepared as homo- or heterogenous polymeric 
particles. In addition inorganic nanoparticles are regularly enclosed by a polymeric 
shell to form hybrid nanoparticles. Here the shell has different functions, for example 
it may stabilise inorganic particles in water while avoiding the leakage of metals or 
allow surface modification.
19
 Sometimes the metal core adds optical, magnetic or 
hyperthermic characteristics to the polymeric particle.
20
 In this thesis, the term 
polymeric particle is used to represent solid polymeric nanospheres of approximately 





 to name but a few although uses in the life science are primarily 
addressed in here.     
Polymeric particles can be divided into two classes with respect to their 
composition; biodegradable, and biostable particles. Biodegradable particles which 
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break down under physiological conditions have been investigated to improve the 
targeting of a variety of diseases. They support the bioavailibity, solubility and 
retention time of potent, but water insoluble drugs. Polylactic acid (PLA) and 
poly(lactic-co-glycolic) acid (PLGA) are the most common building blocks of 
biodegradable polymeric particles.
23
 In contrast, biostable polymeric particles are 
mainly prepared from styrene and (meth)acrylate monomers and can be modified in a 
variety of ways, while not being degraded inside cells. As such, they are often 
suitable for a variety of applications as research tools in the life sciences.  
The number of biomedical applications employing polymeric particles has 
increased dramatically over the last decades. This emanates from the particle’s 
characteristics which can be fine-tuned to address chemical, physical and biological 
problems by varying the polymer composition.
24
 Furthermore, particle surfaces can 
be modified by conjugation of bioactive molecules, drugs or fluorophores and 
importantly the particles are able to cross the cell membrane.    
   APPLICATIONS OF POLYMERIC PARTICLES. The ability of polymeric particles to 
cross the cell membrane was established many years ago
25
 and has enabled the 
development of polymeric particles as carriers of bioactive compounds into cells. 
Those compounds range from small molecules such as sensors to large 
macromolecules, e.g. proteins and nucleic acids. The translocation of these 




The ability to measure a wide variety of cellular parameters reveals important 
information about the physiological state of a cell and has the potential for early 
diagnosis of diseases which would otherwise not be detected.
26
 For example, the 
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 as well as pH
29
 values have 
been determined inside cells using fluorescent sensor molecules attached to 
polymeric particles (Figure 1.2a). In addition oxygen
30
 (on bacteria cell surfaces) and 
glucose
31
 concentrations have been measured using polymeric sensor particles. The 
rational design of polymeric nanoparticles has also allowed the identification of 
apoptotic cells by enzymatic cleavage of a peptide sequence releasing a fluorophore 
which was previously quenched when attached to the particle.
32
 Real-time 
measurement of protein kinase activity in cells has also been achieved by 
phosphorylation of a specific peptide sequence resulting in the dissolution of the 
particle and release of a previously quenched fluorophore (Figure 1.2b).
33
    
 
 
Fig. 1.2. Polymeric particles for sensing: (a) sensing of ions by dyes whose 
fluorescence is influenced by the presence of the respective ions; and (b) protein 
sensors releasing quenched fluorophores after enzymatic cleavage.  
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The delivery of macromolecules, i.e. proteins and nucleic acids,  could contribute 
to improvements in the field of therapeutics, however they require a carrier to be 
internalised into cells.
34,35
  Proteins have also been conjugated onto polymeric 
particles either in a covalent or non-covalent fashion followed by cellular 
delivery.
36,37
 The delivery of nucleic acids is the foundation of gene therapy by 
which corrective DNA is introduced to replace mutant genes or introducing new or 
down-regulating genes to treat diseases.
35
 Proteins can also be down-regulated in a 
process known as gene silencing requiring the delivery of small interference RNA 
(siRNA) into the cytosol. Alexander demonstrated the attachment of siRNA via 
disulphide bonds onto polymeric particles and subsequent cellular delivery and 
silencing of eGFP.
38
 Analogous, biotin-labelled (non-encoding) DNA has been 
conjugated onto streptavidin-functionalised particles and internalised into cells.
39
 The 
incorporation of plasmid DNA into biodegradable polymeric nanoparticles has 
enabled gene expression following the intracellular degradation of the particles and 
release of DNA.
40
 Both techniques may provide promise in tackling a variety of 
currently incurable diseases.  
The ability of the particles to cross biological membranes also opens the door to 
cellular imaging using fluorophore-labelled polymeric particles that can be tracked 
within mixtures of non-labelled cells.
41,42
 Recently, non-fluorescent polymeric 
particles were prepared and demonstrated to turn-on fluorescence following cellular 
uptake.
43
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1.3 Synthesis of polymeric particles 
The technique employed in preparing polymeric nano and submicroparticles is 
mainly governed by the size of the required particles. The use of dispersion 
polymerisation yields particles with a size between 100 nm and 2,000 nm, smaller 
particles (50 nm – 300 nm) can be prepared by emulsion polymerisation, and 
particles smaller than 100 nm can be obtained using miniemulsion polymerisation.
45
 
The processes are free-radical polymerisations of hydrophobic monomers in either 
water and/or organic solvent mixtures. Dispersion polymerisation is characterised by 
an aqueous solution of monomer droplets mixed with organic solvents. By using a 
water-insoluble radical initiator, the particles are formed in the monomer droplets.
46
 
In contrast, the addition of an emulsifier to an emulsion polymerisation results in 
micelles and small amounts of monomer droplets, while water-soluble radical 
initiator facilitates particle formation inside the micelles rather than in the droplets. 
Furthermore, the number of monomer droplets can be dramatically increased and 
size decreased by external sheering forces to make a miniemulsion.
47
 
EMULSION POLYMERISATION. The formation of particles via emulsion 
polymerisation has been described by the micelle-nucleation model developed by 
Harkins, Smith and Ewart.
48,49
 The aqueous polymerisation mixture contains non-
water soluble monomers, surfactant and a water-soluble initiator (Scheme 1.1). The 
surfactant forms micelles which contain a small amount of monomer but mainly the 
monomer is stored in large monomer droplets. Following the radical initiation, the 
radical starter reacts with monomer molecules dissolved in water thus increasing its 
hydrophobicity. Since the micelles vastly outnumber the monomer droplets, the 
oligomeric radicals formed enter the micelles and continue to polymerise with the 
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present monomers. Micelles containing a growing polymer chain are known as 
“particle nuclei” and are fed by monomers present in the droplets and micelles. 
Following the complete consumption of monomers, the polymerisation ends 
resulting in a dispersion of polymeric particles in water.
50
    
 
 
Scheme 1.1. Micelle nucleation model of the emulsion polymerisation: (i) formation 
of micelles and monomer droplets in water; (ii) water-soluble radical initiator reacts 
with the monomers dissolved in water before entering micelles (particle nuclei); (iii) 
the monomer transfers into micelles from the monomer droplets and polymerises; 
and (iv) particles stabilised by surfactants are formed.   
 
A disadvantage of emulsion polymerisation is the excess of surfactant following 
the particle synthesis which is difficult to remove from the resulting dispersion. 
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is critical to gain the desired particle size and to stabilise the resulting particles. To 
avoid excess surfactant, emulsifier-free emulsion polymerisation can be used. The 
stability of the particles formed relies on the addition of charged monomers, such as 
acrylic acid
51
 or para-vinylbenzylamine hydrochloride
52
 resulting in negatively and 
positively charged particles, respectively. The charges provide the necessary 
repulsion forces to avoid agglomeration. An additional feature of these particles is 





1.4 Aims  
Polymeric particles that can be modified with a wide range of compounds such as 
fluorophores, sensors and proteins have been developed for a broad range of 
intracellular applications within the Bradley group.
53
 To broaden their application, 
the aims of this thesis were to further develop and study chemical and biological 
properties of the particles. Although the work presented in this thesis is restricted to 
polystyrene-based particles, these studies are exemplified using nanoparticles of all 
sizes and compositions.  
The modification of nanoparticles with a variety of compounds to boost their 
function is now standard laboratory pratice. However, the determination of chemical 
transformations on a particle’s surface is often limited and empirical in nature. One 
aim of this thesis was to use zeta potential measurements for the rapid analysis of 
particle functionalisations. Specifically, the ability to follow multi-step modifications 
was investigated.  
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In general, particle-based biological applications require fluorescent labelling of 
the particles. Thus, another aim of this thesis was the synthesis and application of 
novel polymerisable fluorophores to enable the comparison of particles which were 
fluorescently labelled during or following the polymerisation process.   
To further improve the properties of nanoparticles and boost their applications, 
dual-functionalised surfaces are often required which allow orthogonal cargo 
conjugation. Novel dual boronic acid and aminomethyl-functionalised particles were 
developed allowing palladium-mediated Suzuki-Miyaura cross-coupling in 
combination with orthogonal amide conjugation onto the particles. The suitability of 
these dual-functionalised paticles for cellular loading was investigated.  
Since nanoparticles are widely used, the effects of surface chemistry were 
analysed; of particular importance being the formation of a protein corona with 

























REACTION MONITORING ON 
NANO AND MICROPARTICLES 
 
Parts of this chapter were previously published as: 
Thielbeer, F., Donaldson, K. and Bradley, M. Zeta Potential Mediated Reaction 
Monitoring on Nano and Microparticles. Bioconjugate Chemistry 2011, 22, 144-150. 
 
2.1 Reaction monitoring on particles 
Nano- and microparticles are routinely functionalised to broaden the scope of 
their possible applications. For example, conjugation of cargos or sensors can add 
additional functionality on particles to allow cellular delivery or sensing in cells 
(Chapter 1). Although, the conjugation of molecules to particles is widely carried out 
and countless different method exists,
24
 the monitoring and analysis of chemical 
modification on-bead remains a challenge.  
REACTION MONITORING ON PARTICLES. Currently the most widely used analysis 
tool for reaction monitoring on particles are colorimetric tests which can identify and 




at times quantify different functional groups. For example, the Kaiser test can be 
used to determine the levels of free amino groups.
54,55
 Other colorimetric methods
56
 
include the Ellman test for thiols
57
 and the Pomonis test for the detection of 
alcohols
58
 to name but a few. Furthermore, surface-group quantifications are also 
available by a range of titration techniques including potentiometry and 
conductometry.
59
 In addition, non-destructive colorimetric or fluorometric assays 
have been designed to correlate dye binding with functional group loading. In these 
assays a dye is adsorbed onto particle surfaces via charge-charge interactions with 
complementary functionalities such as amino
60
 or carboxyl groups
61
, generating 
quantitative information. Recent modifications allow surface interactions with 
metals
62
 or macrocyclic host complexes
63
 followed by visualisation with 
complementary dyes. Moreover, surface groups have also been quantified by 
peptide
64
 or protein attachment.
65
 The group of Whitesides demonstrated the ability 
of magnetic levitation to analyse chemical transformations on solid-phase resins.
66
 
However, these methods are laborious and typically have high material demands. 
Alternatively, analytical methods, such as NMR have been applied to particle 
analysis based on the integration of NMR-active nuclei in the conjugated molecule.
67
 




F part of the 
molecule that was conjugated to the solid support and a successful conjugation was 




 Furthermore, specifically designed NMR 
techniques, such as magic angle spinning, can be used to monitor reactions on 
particles.
69,70
 Fourier-transform infra-red and Raman spectroscopy have also been 








Mass spectrometry of compounds attached to the particles has been applied to 
gain information regarding its chemical composition. To achieve on-bead analysis a  
photocleavable linker
72
 has to be attached to the particles prior to MALDI-MS. 
However, exposing the particles to cleavage solution has also been shown to be 
sufficient for mass spectrometric analysis.
73,74
 
The surface composition, determined by X-ray photoelectron spectroscopy (XPS), 
can also be used to measure, qualitatively and quantitatively, the surface chemistry 
make-up of particles.
75
 However, since XPS analysis gives information only of the 
top several nanometers of the surface, the avoidance of contaminations is crucial, 
which can be a major drawback if any compound binds non-specifically to the 
surface.
76
 Finally, a simple way to verify successful conjugation is the incorporation 





Since various particles and modifications are commonly employed, there is an 
urgent need for a practical, inexpensive, and universal method to analyse chemical 
modifications on them. Herein, the usage of zeta potential measurements is described 
as a convenient tool which allows chemical reactions to be quickly monitored on 
particles with minimal sample preparation. 
 
2.2 Synthesis and characterisation of polymeric particles  
Polymeric particles were synthesised to investigate the ability of the particle’s 
zeta potential to be used as an indicator of reaction progress on solid particles. In this 
thesis, aminomethyl-functionalised polystyrene-based particles were prepared by an 
emulsifier-free emulsion polymerisation, while the size of the particles used was 
approximately 200 nm representing nano as well as micro-sized solid particles.  




PARTICLE SYNTHESIS. Polystyrene particles were synthesised by an emulsifier-
free emulsion polymerisation. The process is similar to the emulsion polymerisation 
as described previously (Chapter 1).
41,52
 However, this method has advantages over 
emulsion polymerisation as the emulsifier is incorporated into the particle structure.
79
 
The polymerisable emulsifier used was para-vinylbenzylamine hydrochloride 
(VBAH) 1 which generated an emulsion of the monomer styrene 2 in water. In 
addition, the incorporation of VBAH into the particle structure creates aminomethyl 
groups on the particle surface for further functionalisations of the particles. 
Furthermore, to improve the stability of the particles, particularly in organic solvents, 
polymer chains were cross-linked with divinylbenzene 3 (DVB).  
Polymerisation of styrene 2, crosslinker DVB 3 (2 mol% with respect to styrene) 
and functional monomer VBAH 1 (3 mol%) in water using the water-soluble radical 
initiator 2,2´-azobis-(2-amidinopropane) hydrochloride (V-50) gave particles 4a 
(Scheme 2.1). On average, circa 40 wt% of the monomers were converted into 
aminomethyl functionalised polystyrene-based particles and stored in water at a solid 
content of 2%.    
 
 
Scheme 2.1. Synthesis of aminomethyl-functionalised polystyrene-based particles. 
 
    FUNCTIONAL MONOMER SYNTHESIS. The monomer VBAH, which is an 
emulsifier, also introduces amino groups onto the particle’s surface. It was 
2                3             1                                                               4a 




synthesised by a Gabriel synthesis followed by acidification in moderate overall 
yield (19%) (Scheme 2.2).
52
 The first step of the Gabriel synthesis involved reaction 
of potassium phthalimide with para-vinylbenzylchloride 5 in DMF. The phthalimide 
6 was isolated in 65% yield after recrystallisation in methanol. The phthalimide 
group was removed using hydrazine hydrate to yield para-vinylbenzylamine 7 in 
64% yield, followed by generation of the salt (VBAH 3) in 45% yield.  
 
 
Scheme 2.2. Synthesis of the aminomethyl-bearing monomer para-vinylbenzylamine 
hydrochloride. 
       
PARTICLE CHARACTERISATION. The main physical characteristics of solid 
particles are size, shape, density, porosity along with surface and chemical 
properties. These characteristics influence the behaviour of the particles within a 
biological environment and determine not only its uptake mechanism, but also 
whether particles could be internalised by cells (Chapter 5).
80
  
SIZE AND SHAPE. Size measurements of a sample give the size distribution of 
particles (PSD) and can be determined by a variety of methods. The most common 
methods are dynamic light scattering (DLS), and analysis of images gained from 
methods such as electron microscopy. These approaches clearly influence the result 
as one is measured in solvent while the other is measured dry. Most sizing techniques 




assume that particles have a spherical morphology to allow measurement of only one 
variable (diameter) in contrast to their actual three-dimensional shape which would 
require three variables (height, length, depth) to be determined. Depending on the 
technique used, the diameter determined is based on one of the three variables, 
hence, varying results can be obtained with different techniques.     
Light scattering measures principally the velocity of particles in solution which is 
related to the particle size. If particles are dispersed in solution they move randomly 
due to Brownian motion. The velocity of this motion can be obtained by firing a laser 
onto the particles and analysing the resulting Rayleigh scattering. The scattered light 
of different particles interferes with each other and analysis of this generates 
information about the velocity of the particles. This velocity can be transformed into 
a diffusion coefficient which is directly related to particle size via the Stokes-
Einstein equation (Equation 2.1).
81
  
Equation 2.1. Stokes-Einstein equation. 
     
     
          
 
D Diffusion coefficient in m
2
/s 
k Boltzmann constant (1.380 × 10
-23
 J/K) 
T Temperature in K 
η Viscosity coefficient in N s/m
-2 
r Hydrodynamic particle radius in m 
Sizes gained from particle dispersions are given as hydrodynamic diameter (dhyd) 
since the technique cannot distinguish between the intimate ion-shell surrounding the 




particle in solution and the solid particle core. In comparison, a dry diameter (ddry) is 
measured by techniques such as electron microscopy. A further characteristic of the 
particle size is the polydispersity index (PDI) which can have a value between 0 
(every particle in the suspension has exactly the same size) and 1 (the size of every 
particle differs). A value below 0.1 typically classifies dispersions as monodisperse.
42
 
The shape, and additionally the dry diameter, of particles can be visualised by 
electron microscopy while the size of the particles determines the technique; 
scanning (SEM, above 200 nm) or transmission electron microscopy (below 200 
nm). Particles 4a are submicron-sized hence SEM was employed to investigate dry 
size and shape of the particles.  
 The size distribution of particles 4a was determined by DLS (quantitatively), and 
SEM (qualitatively). The intensity-based distribution resulted in a hydrodynamic 
diameter of 232 nm with a PDI of 0.027 demonstrating monodisperse particles in the 
submicron range (Figure 2.1a). These results were verified by SEM with an expected 
slightly smaller dry diameter of (202 ± 10) nm and uniform particles with a spherical 








Fig. 2.1. Particle size distribution of aminomethyl functionalised polystyrene-based 
particles 4a: (a) light scattering, dhyd = 232 nm, PDI 0.027; and (b) scanning electron 








 SURFACE. Solid particles can be further characterised by their surface properties 
which play a crucial role in the stabilisation of particle suspensions as well as being 
important for the ability to modify the particles as necessary for a particular 
application.  
The surface of particles 4a contains amino groups originating from VBAH which 
provide stabilisation of the particles by electronic repulsion between adjacent 
protonated amino groups. These groups can also be further modified via standard 
amide-bond formation chemistry. To evaluate the quantity of amino groups on the 
particles a quantitative Kaiser test was carried out
55
 giving an amino group loading of 
(135 ± 2) µmol/g.  
ZETA POTENTIAL. The particle surface was also characterised by its zeta potential 
which correlates to the charge of particles and can be simplistically described by the 
Gouy-Chapman-Stern model (Figure 2.2). A positively charged particle such as 4a 
will affect nearby ions dissolved in the suspension medium. The surface of the 
particles is highly positively charged (quantified by the surface potential) and attracts 
negatively charged counter ions. These ions form a tightly adsorbed monolayer on 
the particle surface. This leads to a linear decrease of the potential resulting in the so-
called Stern potential. A diffuse layer follows which contains ions which are still 
attracted by the particle and its surrounding Stern layer but are more loosely bound. 
A boundary exists between ions of the diffuse layer which will move with the 
particle and those which will not. The potential measured at this boundary is called 
the zeta potential which is also the only easily quantifiable potential using current 
techniques.
82
     
 












Fig. 2.2. A positively charged particle and its interaction with ions in the 
suspension medium. 
 
Zeta potential measurements of particles depend in particular on the ionic strength 
and the pH of the suspension medium. The density of counter ions and possible 
multi-charged counter ions will influence zeta potential measurements. Multi-
charged counter ions have a greater Coulombic attraction to the particle surface 
hence reducing the particle charge more than single charged ions which also affects 
the zeta potential. Furthermore, the pH of the suspension medium influences the zeta 
potential. For example, aminomethyl functionalised particles 4a have a protonated 
amino group at pH 7 and therefore a positive zeta potential. An increase of the pH 
leads to a decrease of the zeta potential due to deprotonation of the amino groups 
(pKa ~ 10).
83
 The particle’s isoelectric point was determined to occur at pH 10 
(Figure 2.3). However, as shown in Figure 2.2 the loss of charge was measured by 
zeta potential which is dissimilar from surface and Stern potential, hence, there are 






























Positively charged particle 




surrounding counter ions. Therefore, an apparent isoelectric point of the particles 
appears although amino groups on the surface are still protonated. 
 
Fig. 2.3. Zeta potential dependency on pH (aminomethyl-functionalised polystyrene 
particles 4a in de-ionised water were titrated against NaOH). 
 
The importance of zeta potential is based on its simple determination via 
measurement of the electrophoretic mobility and its value for the prediction of 
suspension stability. As a rule of thumb zeta potentials higher than ±18 mV give 
stable polymer lattice suspensions.
84
 Knowledge of suspension stability is required 
for a variety of dispersions such as consumer products (paints and adhesives) or the  
destruction of unwanted colloidal suspensions (water purification).
85
 
Herein, zeta potentials were measured at pH 7.4 in 10% PBS to provide a stable 
environment and comparative measurements of different samples. Electrophoretic 
mobilities were determined by laser Doppler velocimetry. The basis of this technique 
is that the particles move in an electric field and are targeted with a laser beam. Due 
to the particle motion the scattered laser beam is phase shifted (Doppler-effect). This 
phase shift is transformed into electrophoretic mobility which in turn can be 
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  Aminomethyl-functionalised polystyrene-based particles 4a had a zeta potential 
of +25 mV at pH 7.4 (Figure 2.4). Thus, according to the rule of thumb described 
above the determined zeta potential is higher than +18 mV hence the particles would 
be expected to form a stable dispersion. These results confirmed the low 
polydispersity and uniform size characteristics of the particle suspension while 
demonstrating a stable dispersion.  
 
Fig. 2.4. Zeta potential distribution of aminomethyl-functionalised polystyrene- 
based particles 4a (zeta potential +25 mV in 10% PBS, pH 7.4). 
 
2.3 Monitoring of particle modifications  
ZETA POTENTIAL OF FUNCTIONALISED PARTICLES. Initially, the zeta potential of 
particles bearing different surface functionalities were investigated. Particular 
attention was paid to the shift in zeta potential following chemical reactions. Since a  
particle’s surface chemistry has a major effect on the zeta potential, the 
aminomethyl-functionalised particles 4a were conjugated to different molecules 
resulting in a variety of surface chemistries (Scheme 2.3). All of the modifications 
were also bench-marked with the Kaiser test
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quantity of the particle suspension (20 µg) was dispersed in 10% PBS (pH 7.4) 
followed by zeta potential measurement (Table 2.1, Figure 2.5).  
 
Scheme 2.3. Synthesis of functionalised particles: (i) N´,N-bis(
t
butoxycarbonyl)-S-
methylurea, TEA in DMF, 60 °C (μw), 30 min; 20% TFA in DMF, 2 h. (ii) adipic 
acid, DIC in DMF, 60 °C (μw), 20 min. (iii) para-sulfobenzoic acid, oxyma, DIC in 
DMF, 60 °C (μw), 20 min. (iv) ε-hydroxycaproic acid, oxyma, DIC in DMF, 60 °C 
(μw), 20 min. (v) Fmoc-Glu(
t
Bu)-OH, oxyma, DIC in DMF, 60 °C (μw), 20 min 
followed by 20% TFA in DMF, 2 h and 20% piperidine in DMF, 2 × 20 min. (vi) 
Fmoc-4,7,10-trioxa-1,13-tridecaneediamine succinamic acid (FmocHN-PEG3-OH), 
oxyma, DIC in DMF, 60 °C (μw) 20 min. (vii) acetic anhydride, pyridine, DMF, 2 × 
20 min). 
 
The starting aminomethyl particles 4a were transformed to the more basic 
guanidinium group 8 by reaction with N´,N-bis-(
t
butoxycarbonyl)-S-methylurea 
followed by TFA-mediated 
t
butyloxycarbonyl carbamate (Boc) deprotection. The 
zeta potential changed from +25 mV to +31 mV due to the increased basicity of the 
15a 




surface. Due to this high zeta potential particles did not aggregate and formed a 
stable monodisperse solution (238 nm, PDI 0.056). Negatively charged surface 
groups were introduced by amide bond formation using diisopropylcarbodiimide 
(DIC) as an activator and adipic acid to generate a carboxylic acid functionality 9 
and oxyma/DIC
86
 with para-sulphobenzoic acid to generate sulphonic functionalities 
10, respectively. A strong negative zeta potential was found after conversion to 
carboxylic acid 9 (–44 mV) and, as expected, even stronger negative values were 
obtained after attachment of the more acidic sulfonic acid 10 (–65 mV). The size and 
PDI of the particles (279 nm and 252 nm, 0.056 and 0.030) were not affected as 
expected since the zeta potential values for both functions were large enough to 
stabilise the particles despite being negative.  
Furthermore, a variety of neutral functionalities were coupled to the aminomethyl 
group. Hydroxyl groups 11 (via oxyma/DIC and ε-hydroxycaproic acid) resulted in a 
slightly negative zeta potential (–7 mV). An increased size of 463 nm was 
determined in combination with an increased PDI of 0.204 which resulted from the 
loss of charge. Conversion to a zwitterionic surface 12 by the attachment of glutamic 
acid was detected with a very broad zeta potential peak with a mean value of –10 
mV. Furthermore, the size distribution was measured to be 1736 nm with a PDI of 
0.901. Aggregation of the particles was expected since the stabilisation is based on a 
net charge and the zwitterionic-functionalised particles have no net-charge, thus they 
have a propersity to aggregate strongly. 
The attachment of a short polyethylene glycol (PEG) spacer was achieved by 
reaction with FmocHN-PEG-OH 14 which was synthesised following the route of 




Zhao et al. (Scheme 2.4).
87
 Diamino PEG 13 was conjugated in a one-pot reaction 
with succinic anhydride and Fmoc-OSu in moderate yields (44%). 
 
 
Scheme 2.4. Synthesis of FmocHN-PEG3-OH 14. 
 
Conjugation of FmocHN-PEG-OH 14 resulted in a zeta potential of +3 mV for 
particles 15a while acetylation of the amino group 16 produced a zeta potential of –5 
mV. The zeta potential values close to zero mV demonstrated the lost charge on the 
particle surface after amino group capping. Moreover, capping induces strong 
aggregation of the particles measured as large particulate size values (1435 nm and 
2270 nm) in combination with high PDI (0.566 and 0.424) representing differently 










Table 2.1. Functionalised particles and their zeta potential, size and PDI. 



























































Fig. 2.5. Zeta potential of aminomethyl and subsequently functionalised polystyrene 
particles. 
 
It should be noted, that the use of the zeta potential for reaction monitoring is 
based on the comparison between the zeta potentials of the initial particle and those 
of the reaction product. It was observed that different batches of aminomethyl-
functionalised polymeric particles had slightly different initial zeta potentials (+25 ± 
3) mV, however, the shifts in zeta potential were significantly greater after surface 
modification. The results demonstrated that zeta potential allows information to be 
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derived regarding the surface chemistry of the particle. Although a quantitative 
relationship between the number of surface groups and the zeta potential cannot be 
achieved, it proved to be a tool useful nonetheless.  
MONITORING MULTI-STEP REACTION SEQUENCES VIA ZETA POTENTIAL. Nano 
and microparticles are increasingly used and modified with multistep reaction 
sequences to attach the desired linkers or functional molecules. It can be difficult to 
follow such sequences on polymeric supports due to the unknown coupling 
efficiencies of different reaction steps. In addition, the reactions are often performed 
in aqueous media involving highly charged biomolecules. To investigate if the zeta 
potential could also monitor multistep reactions, a reaction sequence on particles was 
analysed by zeta potential measurements.  
A common coupling sequence on particles includes the addition of a spacer such 
as polyethylene glycol (PEG). Scheme 2.5 represents the ability to use zeta potential 
to directly follow such a reaction sequence. The initial charge-stabilised 
aminomethyl polystyrene submicron particles 4b had a zeta potential of +26 mV. 
The amino groups were coupled to Fmoc-protected PEG3-spacer. Treatment with 
acetic anhydride capped the remaining, non-accessible amino groups 15b. A small 
reduction in zeta potential to –2 mV (before capping -1 mV) was observed. Fmoc 
deprotection gave particles with free amines on the particle’s surface 17 and 
therefore a strongly positive zeta potential (+31 mV). Finally, coupling of adipic acid 
18 onto the particle surface resulted in a negative zeta potential (–39 mV) 
representing the carboxylic functionality. The three-step reaction sequence was 
easily monitored by notable changes in zeta potential without significant sample 
preparation, loss of material, or chemical cleavage from the particles. This 




demonstrates that zeta potential is an excellent tool to follow direct on-particle 
modifications without necessary cleavage or introduction of specific spectroscopic 









Scheme 2.5. A multistep reaction analysed by zeta potential monitoring of particles. 
REACTION CONTROL. Commonly used functionalities in nano and microparticle 
bioconjugates are thiol and transition metal-bearing ligands. A thiol containing 
molecule can be easily coupled to a variety of biomolecules, e.g. via maleimides 





functionalities are also used due to their ability to bind the widely-used His-tag and 
therefore non-covalently link proteins to particles.
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Thiols were generated on the particles by coupling 3,3′-dithiopropionic acid 
(DTPA) to the aminomethyl groups of particles 4b followed by subsequent reduction 
with tris(-2-carboxyethyl)phosphine (TCEP). The first coupling resulted in a 



























surface 19 (–29 mV). The following reduction with TCEP in PBS gave free thiol 
groups 20 on the particle surface with a zeta potential value of –18 mV (Scheme 2.6). 
This value was close to that expected due to the relatively acidic nature of the thiol 
group (pKa ~ 9).
91
 The data from the zeta potential analysis was also verified by a 
positive Ellman test
57
 proving the presence of free thiols, although not quantitative 
(Scheme 2.6). 
Another reaction sequence, which is not easily monitored by current methods, is 
the introduction of carboxylic acid ligands, which are commonly used for binding 
transition metal bearing complexes. Initially, the synthesis of carboxylic acid bearing 
particles 18 was followed, yielding particles with a zeta potential of –39 mV. The 
commonly used N-(5-amino-1-carboxypentyl)iminodiacetic acid (NTA)-linker, 
containing three carboxylic acid moieties, was also introduced to give 21 with a 















Scheme 2.6. Reaction control: (a) synthesis and zeta potential monitoring of thiol-
functionalised and (b) tricarboxylated particles. 
 
These two experiments show the ability of zeta potential to verify reactions which 
are difficult to analyse with other common techniques. A decrease in the strength of 
the surface acid, from carboxylic acid to thiol, was clearly observed as a change in 
zeta potential. Similarly, a notable difference in zeta potential values was detected 
when the number of carboxylic functionalities increased. 
 
2.4 Conclusion 
The use of nano and microparticles has increased dramatically with novel 
applications in chemistry and in the life sciences. An increasing number of particles 
are being chemically modified by attachment of different molecules including 
proteins and nucleic acids leading to a variety of functionalities. However, the 
















































chemical analysis of the modified particles has been difficult and remains a 
challenge. Indeed, in many cases it is just assumed that the reaction has taken place. 
Herein, the ability of the zeta potential was demonstrated as a practical, easy method 
to follow conjugations on nano and microparticles. 200 nm aminomethyl-
functionalised submicron polystyrene-based particles, representing nano and micro 
sized particles, were employed to couple a variety of different acidic, basic and 
neutral groups. The zeta potential values of different surface modified particles 
correlated to the nature of chemical modification and demonstrated the strength of 
the technique. Furthermore, a multistep coupling sequence was followed by zeta 
potential measurements. Finally, zeta potential was used to analyse modifications 
which are difficult to follow using conventional analysis techniques. Changing from 
amine to carboxylic acid or thiols as well as the number of presented acids was also 
verified by measuring the shift in zeta potential values on the respective particles.
92
 
The presented method of reaction monitoring by zeta potential gives a qualitative 
analysis of reactions on particle surfaces. This technique could be applied to other 
areas such as reaction monitoring on non-polymeric particles
93
 or bulk polymer 
surfaces for which zeta potentials are also obtainable as current titration or colour 
tests fail but a fast and easy quantitative analysis of surface modifications is 
desirable.  
The presented zeta potential-based method is universal, fast, and convenient, and 
simplifies the analysis of reactions carried out on nano and microparticles. It has 
been demonstrated that zeta potential measurements are a useful method with the 
ability to directly analyse suspensions of nano and microparticles, and can easily be 

















NANO AND MICROPARTICLES  
 
Parts of this chapter were previously published as: 
Thielbeer, F. Fluorescein Synlett 2012, 23, 1703-1704. 
Thielbeer, F., Chankeshwara, S. V.  and Bradley, M. Polymerizable fluorescein 
derivatives: synthesis of fluorescent particles and their cellular uptake. 
Biomacromolecules 2011, 12, 4386-4391. 
 
3.1 Fluorescent particles  
Nano and microparticles can be functionalised with a variety of compounds to 
boost their own or adjoin additional properties enabling them to be used in biological 
or medicinal studies. Standard modifications include labelling giving the ability to 
track the particles, verify their location and/or sense their environment. To achieve 
this, particles can be conjugated to imaging agents. The most common method of 




particle detection is fluorescence, although numerous other methods such as 
magnetic resonance imaging,
94
 or positron emission tomography
95
 exist.  
FLUORESCENCE. Fluorescence describes the emission of light (blue band), from a 
molecule following previous absorption of lower wavelength (higher energy) light 
(red) (Figure 3.1a). This is achieved when an electron moves from the ground state 
(S0) into the multiple vibrational levels of the first excited state (S1) (1→2, Figure 
3.1b). Internal conversion reduces the energy of the molecule to the lowest 
vibrational state of S1 (2→3, Figure 3.1b). The length of time the fluorophore 
remains in its excited state is known as its fluorescence life-time. Finally, the excited 
molecule decays with radiative emission of light (fluorescence) (3→1, Figure 3.1b). 
A fluorescent dye can be characterised by its absorption and emission profile, 
quantum yield and fluorescence life time. The quantum yield Φ describes how 
efficiently the molecule converts absorbed energy into emitted light.
96
 







Fig. 3.1. Fluorescence: (a) excitation (red) and emission (blue) profile of a 
fluorophore; and (b) Jablonsky diagram of fluorescence. 
 
FLUORESCEIN. Fluorescein is the probably most widely used fluorophore. Its 
numerous applications in particular in the life sciences are based on its robust and 

















































biologically favourable properties. It has a high quantum yield (0.93), while the 
readily available argon-ion laser (λ = 488 nm) can excite fluorescein, it shows good 
water solubility, while commercially available derivatives allow biomodification. 
However, the fluorescence of fluorescein is strongly pH dependent. Neutral 
fluorescein is in equilibrium between the lactonised 22a and open form 22b (Scheme 
3.1). The opened lactone ring is required for the fluorescent properties. However, 
neutral fluorescein (22a/22b) has a relatively low quantum yield of 0.30 which is 
even lower upon protonation (22c) (Φ = 0.18). In contrast, deprotonation yields the 
monoanionic species 22d with an increased quantum yield of 0.37. Upon further 
deprotonation of 22d the highly fluorescent dianion 22e is formed with a quantum 
yield of 0.93. These characteristics are important for fluorescein-based applications 
with the pH-values crucial for the ability to form the highly fluorescent dianion with 
good fluorescent properties.
97
 Indeed, it has been shown that modifications of the 






Scheme 3.1: Ionisation equilibria of fluorescein and fluorescence properties  
(pKa,1 = 2.1; pKa,2 = 4.3; pKa,3 = 6.4). 




PREPARATION OF FLUORESCENT PARTICLES. In general, the introduction of 
fluorescent dyes into or onto particles can be achieved by dye incorporation during 
the polymerisation or following the polymerisation process.  
Most commonly, particle labelling occurs post-polymerisation where dyes can be 
deposited onto or into the particle by solvent evaporation,
99,100
 or entrapped by 
particle swelling and subsequent shrinkage (Figure 3.2).
101
 However, these types of 
particles are vulnerable to dye-leakage.
102
 A route to reduce dye-leakage is the 
entrapment of dyes followed by polymer shell formation on top of the dye. Zhang
103
 
deposited dyes on the particle surface and subsequently trapped them by on-surface 
polymerisation of undecylenic acid 23 and crosslinker divinylbenzene 3 (Figure 
3.2a). A conventional method is to fluorescently label polymeric particles by 
covalent attachment of dyes onto the surface groups, e.g. amine or thiol chemistry 
(Figure 3.2b).
104,105
 This type of conjugation leads to covalent attachment and allows 
long-term use and storage without leakage of the fluorophores. However, covalent 
attachment reduces the number of surface functionalities available for conjugation of 
other cargos although this can be avoided by the application of bi-functional linkers 









Fig. 3.2. Routes to generate fluorescent particles after polymerisation: (a) dye-
trapping; and (b) dye-conjugation. 
 
 
Alternatively, particle labelling can be achieved in situ during the polymerisation 
process (Figure 3.3). The simplest approach is the addition of a hydrophobic dye into 
the polymerisation mixture which is then trapped in the particle (Figure 3.3a).
107,108
 
However, due to lack of covalent bonds between dye and polymer, the dye can still 
leak out of the particle. This limits the conditions that a particle can be exposed to for 
chemical transformations. Another strategy uses fluorescent polymers, such as 
poly[2-methoxy-5-(2-ethylhexyl-oxy)-1,4-phenylenevinylene (MEH-PPV) 24, 
poly[(9,9-dioctylfluorenyl-2,7-diyl)-co-(1,4-benzo-{2,1′,3}-thiadiazole)] (PFBT) 25 





 of the fluorescent polymers into particles 
(Figure 3.3b). Another approach involves fluorescent monomers that can be added to 
the polymerisation process.
112
 This approach has the advantage of generating a truly 
homogenous distribution of fluorescence giving particles with a high number of 
available surface functionalities and long-term fluorescent stability. In theory, a 




broad range of fluorophores can be employed. However, the number of fluorescent 
particles which have been synthesised following this route is limited due to the small 





 and boron-dipyrromethene (BODIPY)
114
 which have 
been conjugated to an acrylic acid unit to give 27a, 27b and 28, respectively or 
nitrooxabenzodiazole linked to a methylmethacrylate to give 29
115
 and vinyl 





Fig. 3.3. Strategies for generating fluorescent particles during polymerisation: (a) 
entrapment; (b) use of fluorescent polymers; and (c) via addition of fluorescent 
monomers. 
 




However, the incorporation of fluorescent monomers has not been studied 
systematically with an analysis of the influence of fluorescence intensity following 
modifications of the dye, or comparison of particle fluorescence when prepared with 
different polymerisable monomers. Herein, the preparation and investigation of 
highly fluorescent particles dependent on varying the fluorescein-based monomers is 
shown. Furthermore, the abilty of these particles to cross cell membranes to allow a 
variety of applications in biology is investigated. 
 
3.2 Polymerisable fluorescein derivatives and their properties 
To form fluorescent particles with direct attachment of the dye, fluorophores with 
a polymerisable functional group were used. The ability to achieve direct particle 
synthesis was investigated by modifying fluorescein 22 with a styryl group. Since the 
fluorescent properties of fluorescein depend strongly on the ability to form the 
dianionic species, three novel fluorescein monomers were synthesised with the 
styryl-functionality in a number of different locations (Scheme 3.2).
*
  
MONOMER SYNTHESIS. The styryl group was introduced on the xanthine moiety of 
fluorescein 22 by transformation of the hydroxy group into an O-triflate 31 followed 
by Suzuki-Miyaura cross-coupling with para-vinylphenylboronic acid to give 
xanthine-styryl fluorescein 32 in moderate overall yield (46%). An alternative 
attachment of the styryl group was achieved by alkylation of fluorescein 22 with 4-
vinylbenzyl chloride giving 33. Saponification of this product selectively removes 
the ester to give O-styryl fluorescein 34 in good overall yield (72%). Since it is well 
established that modifications of the xanthine moiety influence fluorescence,
98,117–119
 
                                                          
*
 Fluorescein derivatives were jointly synthesised with Dr S. V. Chankeshwara. 




the styryl group was also introduced on the phthalic moiety. This fluorescein 
derivative was synthesised by Suzuki–Miyaura cross-coupling of para-
vinylphenylboronic acid and 5-iodofluorescein 35
115
  (synthesised by a Sandmeyer 
reaction of 5-aminofluorescein 36) to give phthalic-styryl 37 in moderate overall 
yield (45%) (Scheme 3.2).  
 
 
Scheme 3.2: Synthesis of polymerisable fluorescein-based monomers. (i) PhNTf2, 
K2CO3, DMF, 80 °C (μw), 30 min; (ii) 4-vinylphenylboronic acid, Pd(OAc)2, PPh3, 
K2CO3, dioxane/water (9:1), 120 °C (μw), 30 min; (iii) 4-vinylbenzyl chloride, 
K2CO3, DMF, 60 °C, 12 h; (iv) LiOH, THF/water (1:1), 50 °C, 6 h; (iii) pH 3, conc. 
HCl; (v) conc. HCl, NaNO2, KI, 0 °C to rt; 2 h; (vi) 4-vinylphenylboronic acid, 
Pd(OAc)2, PPh3, K2CO3, dioxane/water (9:1), 120 °C (μw), 30 min. 
 




FLUORESCENT PROPERTIES OF THE MONOMERS. Modification of the 
fluorophores, in particular altering their conjugated system, may affect their 
fluorescent properties. Figure 3.4 shows the fluorescence spectra of monomers 32, 34 
and 37 in comparison to 5(6)-carboxyfluorescein. The fluorescence spectra were 
recorded in phosphate buffered saline (PBS) at pH 7.4 with an excitation wavelength 
of 488 nm. As expected, the change in the xanthine moiety had a dramatic effect on 
fluorescence, showing undesirable interference with the conjugated system by 
suppressing the fluorescent anionic quinone form. Transformation of the hydroxyl 
group to the styryl group 32 reduced fluorescence by over 30-fold. The conjugation 
of the styryl moiety as ether 34 restored some of this fluorescence but this was still 4-
fold lower than that of 5(6)-carboxyfluorescein. It is known that modifications on the 
phthalic anhydride functionality generally have a minor effect on the fluorescence 
intensity. In fact, the attachment of the styryl group to the 5-position of fluorescein 
gave comparable fluorescence to 5(6)-carboxyfluorescein. An image of the four 
compounds at 10 µM in PBS clearly demonstrated the different effects of the styryl 
modifications. 5(6)-carboxyfluorescein and 37 gave very bright yellow solutions, 34 
was only slightly yellow, while 32 had more of a brown coloration (Figure 3.5). 
 





Fig. 3.4. Fluorescent properties of fluorescein monomers 32, 34, 37 and 5(6)-
carboxyfluorescein (λex = 488 nm, 10 nM solution in PBS, pH 7.4). 
 
 
Fig. 3.5. Solutions of fluorescein monomers 32, 34, 37 and 5(6)-carboxyfluorescein 
(CF) (10 µM solutions in PBS, pH 7.4). 
 
3.3 Synthesis of fluorescent polymeric particles and their properties 
PARTICLE SYNTHESIS AND CHARACTERISATION. The fluorescent monomers were 
used to prepare fluorescent polymer particles to investigate the effects of the 



































polystyrene-based particles were synthesised by an emulsifier-free emulsion 
polymerisation using styrene 2 and the crosslinker divinylbenzene (DVB) 3 with 
functionality introduced by addition of para-vinylbenzylamine hydrochloride 
(VBAH) 1
41,52
 with the addition of fluorescent monomers 32, 34 or 37 (3%) (Scheme 
3.3a). Polymerisation gave monodisperse particles (average diameter of 200 nm) 
with a polydispersity index (PDI) below 0.1 for all particles (Table 3.1). 
 
 
Scheme 3.3. Synthesis of fluorescent polymeric particles: (a) co-polymerisation of 
















4c 224 nm 0.014 78 µmol/g 
38 189 nm 0.099 121 µmol/g 
39 217 nm 0.043 114 µmol/g 
40a 187 nm 0.041 105 µmol/g 
 
SEM images demonstrated that all particles had a uniform spherical morphology 
with particle sizes determined by dynamic light scattering (Table 3.1 and Figure 3.6). 
Quantification of the aminomethyl groups on the particles demonstrated that these 
were present at similar levels to those found on unlabelled particles indicating that 






























































Fig. 3.6: Sizes of the fluorescent polymeric particles 4c, 38, 39 and 40a (4c: 224 nm, 
PDI: 0.014; 38: 189 nm, PDI 0.099; 39: 217 nm, PDI 0.043; and 40a: 187 nm, PDI: 
0.041. Scale bar equals 1 µm). 
 
FLUORESCENT PROPERTIES OF THE PARTICLES. Analysis of the fluorescent 
properties of the particles was carried out with a flow cytometer which is normally 
used for analysing cells but also analyses the morphology and fluorescent properties 
 





Particles 39  
Particles 40a  




of any three-dimensional object. In principal, one object at a time flows through a 
laser beam and scatters it. The scattered light is detected, separately, as forward 
(FSC) and sideward (SSC) scatter which carries information about size and 
granularity, respectively. Typically the received data are important for cellular 
analysis to distinguish cell-types and even identify properties of cell populations such 
as viability. Moreover, laser light irradiation can also be used to measure 
fluorescence intensities of objects or cells containing fluorescent dyes. A flow 
cytometer is generally equipped with monochromatic light sources of different 
wavelengths to allow measurement of a variety of fluorescence signals 
simultaneously.  
The fluorescent particles prepared herein were excited at 488 nm and the emission 
filter was set to 515-545 nm to quantify the fluorescein-based fluorescence intensity 
of the particles. The two-dot plot (SSC versus FSC) of unlabelled particles 4c (grey) 
and fluorescent particles 40a (green) demonstrates that the morphology was similar 
for both types of particles (Figure 3.7a). Following gating of the particles, a two-dot 
plot (fluorescein fluorescence versus FSC) demonstrates the fluorescence shift of 
fluorescein-styryl polymerised particles in comparison to unlabelled particles (Figure 
3.7b). The fluorescence was quantified and determined to be not significant for 
unlabeled particles 4c (< 150 AU) (Figure 3.7c). As a positive control, unlabelled 
particles 4c were conjugated to 5(6)-carboxyfluorescein to give 41 (Scheme 3.3b) 
with a fluorescence intensity of approximately 10
4
 AU. The xanthine-styryl particles 
38 (8000 AU) had a lower fluorescence than the secondary conjugated particles 41. 
However, the fluorescence intensity approximately doubled for 39 (24,000 AU) 
which incorporated the O-styryl monomer. A further 5-fold fluorescent enhancement 




resulted from the use of the fluorescein derivative functionalised via the phthalic 
moiety with styryl 40a (50,000 AU). This demonstrated the advantages of 










Fig. 3.7. Fluorescent properties of polymeric particles: (a) two-dot plot (sideward 
scatter vs. forward scatter) of unlabelled particles 4c (grey) and 40a (green); (b) two-
dot plot (fluorescein fluorescence vs. forward scatter) of unlabelled particles 4c 
(grey) and 40a (green); and (c) fluorescence quantification (4c: unlabelled particles; 
41: 5(6)-carboxyfluorescein secondary functionalised particles; 38: xanthine-styryl 
polymerised particles; 39: xanthine-O-styryl polymerised particles; 40a: phthalic-
styryl polymerised particles). 
 
It has been shown previously that surface attachment of fluorophores can lead to 
self-quenching
120,121
 which can be avoided using fluorescent monomers that 
















































































































fluorescent intensity of 5(6)-carboxyfluorescein is reduced following amide bond 
attachment.
119,122
 This attachment increases the donor-excited photoinduced electron 
transfer (dPet) effect. Herein, the excited molecule (xanthine moiety of fluorescein) 
donates its energy via an electron transfer into the acceptor molecule (phthalic 
moiety of fluorescein) resulting in loss of fluorescent emission (Figure 3.8b).      
 
Fig. 3.8. Advantages of polymerised fluorescein and surface-attached fluorescein: (a) 
illustration of the self-quenching surface with attachment and homogenous 
distribution of fluorescein; and (b) dPET-effect in fluorescein. 
 
PARTICLE MODIFICATION. An additional feature of the fluorescein particles 
generated here is the availability of the amino groups for conjugation. Particles 40a 
were further investigated and coupled to FmocNH-PEG3-OH 14 followed by Fmoc-
removal with the reactions monitored by the particles’ zeta potential (Figure 3.9).
92
 
Initially, particles 40a had a zeta potential of +18 mV which after FmocHN-PEG-OH 
coupling 42 was reduced to -6 mV due to the loss of charge. A zeta potential of      
+6 mV was measured after Fmoc-deprotection 43a. Spacer coupling was carried out 
with maintenance of fluorescence throughout the synthesis. 




Fig. 3.9. Reaction monitoring on fluorescent particles: (a) reaction sequence; and (b) 
zeta potential mediated reaction monitoring. 
 
3.4 Cellular uptake of fluorescent polymeric particles  
The cellular uptake of particles was investigated by flow cytometry and 
fluorescence microscopy. The principal to determine the fluorescence of cells 
following particle internalisation is identical to the above described method for 
analysis of fluorescent particles. Human embryonic kidney 293T cells (HEK293T) 
and cervical cancer cells (HeLa) were used since they are regularly used in biological 
experiments. Therefore, a good cellular uptake would indicate compatibility with a 
wide range of potential applications in the life sciences.  
The influence of particle uptake on cells is shown in the two-parameter plots (FSC 
versus SSC and FSC versus fluorescein intensity) in Figure 3.10. The healthy, 
untreated population of HEK293T cells was identified by its granularity (SSC 
distribution) and volume (FSC distribution) as shown by the gated image (Figure 
3.10a). Following internalisation of particles 40a, granularity was seen to be affected 




due to the intracellular presence of the particles (Figure 3.10b). The cellular uptake 
of particles is size-dependent, amongst other factors (Chapter 5), and up to 
approximately 1,000 large nano to submicron-sized particles can be taken up by each 
cell.
123
 These particles also scatter light and, hence, shift the SSC signal, however 
this shift does not indicate an unhealthy cell population.
124,125
 Therefore, the control 
gate was enlarged to include cells with high particle internalisation with the healthy 
cell population identified by cell volume (Figure 3.10b). The cellular uptake of 
fluorescent particles was identified by a significant shift to higher fluorescence 
following exposure to particles 40a (Figure 3.10c). The same results were 
determined for HeLa cells with particles demonstrating high cellular uptake in 









































Fig. 3.10. Two parameter plot of flow cytometric analysis of particle uptake: (a) 
untreated HEK293T cells and gating (FSC vs. SSC); (b) untreated HEK293T cells 
(grey) and HEK293T cells with particles (green) 40a (FSC vs. SSC); (c) untreated 
HEK293T cells (grey) and HEK293T cells with particles 40a (green) (FSC vs. 
fluorescein fluorescence); (d) untreated HeLa cells and gating (FSC vs. SSC); (e) 
untreated HeLa cells (grey) and HeLa cells with particles (green) 40a (FSC vs. SSC); 
and (f) untreated HeLa cells (grey) and HeLa cells with particles 40a (green) (FSC 
vs. fluorescein fluorescence). 
  
Figure 3.11 (HEK293T) and 3.12 (HeLa) summarises the results of cellular uptake 
of in situ polymerised fluorescein-containing particles 40a and 5(6)-
carboxyfluorescein-conjugated particles 41. The fluorescent intensity of the cells 
increased gradually with higher particle concentrations for both sizes. However, the 
fluorescence of phthalic styryl particles was approximately 4-5-fold higher in 
comparison to 5(6)-carboxyfluorescein coupled particles at the same concentration. 
Representative histograms verified the good cellular uptake and high fluorescent 
intensities at varying concentrations. The cellular uptake data were in accordance 
with the fluorescence measurements of the particles which demonstrated a 4-5-fold 
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increase in fluorescence of the phthalic styryl particles 40a in comparison to particles 
41 which fluorophore coupled using more conventional methods. Microscopy of 

























Fig. 3.11: Cellular uptake of fluorescent particles by HEK293T cells: (a) 
fluorescence intensity of cells treated with particles 40a (dark blue) and 41 (light 
blue) (n = 3); (b) fluorescence histograms of cells treated with particles 40a (particle 
concentration increases with shade); (c) fluorescence histograms of cells treated with 
particles 41 (particle concentration increases with shade); and (d) microscopy images 
following internalisation by HEK293T cells. (i) bright-field; (ii) green: fluorescent 
particles 40a or 41 (λex = 488 nm); (iii) blue: nuclei stain Hoechst 33342 (λex = 405 
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Fig. 3.12: Cellular uptake in HeLa cells: (a) Fluorescence intensity of cells treated 
with particles 40a (dark blue) and 41 (light blue) (n = 3); (b) fluorescence histograms 
of cells treated with particles 40a (particle concentration increases with shade); (c) 
fluorescence histograms of cells treated with particles 41 (particle concentration 
increases with shade); and microscopy images following internalisation in HeLa cells 
(i) bright-field; (ii) green: fluorescent particles 40a or 41 (λex = 488 nm); (iii) blue: 




Three novel fluorescein monomers in which the polymerisable styryl groups were 
attached in different positions were synthesised and their fluorescent properties 
analysed. Conjugation to the xanthine moiety of fluorescein considerably reduced 
fluorescence for both carbon-carbon and ether linkages. The modification via the 
phthalic anhydride moiety resulted in a similar fluorescence to 5(6)-
carboxyfluorescein. The monomers were used to prepare monodisperse polymer 
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particles of ca. 200 nm with inherent fluorescent properties arising from the 
fluorescent monomers. Particles with xanthine-styryl fluorescein 38 had the lowest 
fluorescence, the fluorescence of ether-styryl-based particles 39 doubled, and a 
further increase was seen for particles using the phthalic-styryl monomer 40a. 
However, in comparison to secondary conjugated 5(6)-carboxyfluorescein particles, 
fluorescent particles 39 (2-fold) and 40a (4-5-fold) had improved fluorescence. The 
polymerisation resulted in evenly distributed fluorophores throughout the particle 
structure thereby avoiding self-quenching effects which resulted from the surface 
attachment of 5(6)-carboxyfluorescein. Moreover, styryl fluorescein polymerised 
particles 40a were also taken up by cells and these exhibited a 4-5-fold increase in 
fluorescence signal over 5(6)-carboxyfluorescein-conjugated particles 41.
126
  
The herein synthesised particles are useful for a variety of applications in 
particular if particle tracking is required. A further enhancement could be achieved 
by amplifying the number of fluorescent dyes and using near infrared dyes which can 
be incorporated by direct polymerisation. This could allow the fluorescent particles 
to be used for in vivo applications.
127
 Moreover, the monomeric fluorophores are not 
limited to particle-based applications. Polymeric surface functionalisation with 
fluorescent dyes
128
 allows, for example, the fluorometric measurement of pH values 
of solutions without addition of compounds.
129
 Moreover, the release of fluorescein 













Parts of this chapter have been submitted for publication as: 
Thielbeer, F., Chankeshwara, S. V., Johansson, E. M. V. and Bradley M. Pd-
mediated bio-orthogonal conjugation of nanoparticles for intracellular delivery and 
targeting. Submitted 2012. 
 
4.1 Biomolecule conjugation to nano and microparticles 
Nano and submicron polymeric particles have gained a prominent position in the 
life sciences due to their wide variety of applications, namely as carriers of 
intracellular sensors or as tools for cellular delivery. Crucial in the preparation of 
these constructs is the controlled attachment and display of bioactive molecules.  
PARTICLE CONJUGATION. A wide variety of bioactive compounds with 
interesting intracellular applications cannot pass through the cell membrane and need 
a carrier to do so (Chapter 5). Increasingly, polymeric particles which have been 




shown to deliver conjugated compounds into the cytosol are used as carriers.
131
 To 
achieve successful delivery, the cargo can be attached to the particles either via a 
cleavable or non-cleavable bond. Herein, a mild conjugation method compatible with 
biomolecules is sought after. An additional desired feature is the controlled 
conjugation of several bioactive molecules onto the same particle but this requires 
orthogonally compatible reaction conditions.
24
 There is increasing demand for 
bioorthogonal coupling, i.e. the ability to carry out chemoselective reactions in the 
presence of functionalities such as amino, carboxyl or thiol groups under 
physiological conditions and/or in the environment of cells.
132
 
 The most common way to conjugate biomolecules is via amino or carboxyl 
groups and the formation of amide (peptide) bonds (Figure 4.1a, b). The acid 
functionality is typically activated to form an active ester which undergoes 
nucleophilic attack by the amine to yield the amide bond. Standard routes to 
activated acids employ carbodimides such as 1-ethyl-3-(3-
dimethylaminopropyl)carbodimide (EDC)
133
 which can be used under aqueous 
conditions, or diisopropyl-carbodimide (DIC) in combination with 
hydroxybenzotriazole (HOBt)
134
 if organic solvents are applicable. Otherwise, the 
acid can be activated via the formation of a succinimidyl ester to react directly with 
free amines. The presence of aldehydes has also been used to generate a secondary 
amine linkage by imine formation and subsequent reductive amination (Figure 
4.1c).
36
 Aldehyde-containing molecules have been conjugated to hydrazine-
functionalised particles via hydrazone ligation (Figure 4.1d).
135
  
A further well-known reaction in the field of bioconjugation generates thioethers 
from maleimides and thiols (Figure 4.1e).
136
 In addition, thiol-functionalised 




particles can be linked via disulphide bridges to bioactive compounds giving an 
intracellular cleavable disulphide linker (Figure 4.1f).
137
 Recently, transition metal-
catalysed bioconjugations, namely copper-catalysed Huisgen cycloadditions, have 
been employed for the funtionalisation of azide-containing particles (Figure 4.1g).
138
 
Moreover, cargos have been bound to particles by non-covalent bond interactions, 
e.g. NTA-bearing particles bound via nickel and a His-tag modified protein
90
 or 





Fig. 4.1. Attachment of biomolecules onto particles: (a) carbodiimide mediated 
coupling; (b) N-hydroxysuccinimide ester mediated coupling; (c) imine formation; 
(d) hydrazone ligation; (e) maleimide mediated coupling; (f) pyridyl disulfide 
mediated coupling; and (g) Huisgen cycloaddition.    
 
An emerging field in particle technology is theranostics,
139
 a combination of 
therapy and diagnostic, which generally requires the incorporation of two functions 
on a particle. A common route is based on the introduction of one function into the 
particle’s interior, while the additional property is attached after polymerisation, e.g. 




a fluorescent core and a bioactive surface modification.
101
 Another route can be 
followed by attaching spacers incorporating two functional groups which can be 
orthogonally deprotected and subsequently modified.
38
 
However, a more elegant route involves the incorporation of two or more 
orthogonal functional groups on the particle’s surface during the polymerisation 
process, in addition to core loading. The group of Boons has prepared gold-core 
nanoparticles with a block-copolymer containing acylhydrazide, amine and azide 
moieties on the particle surface. They also demonstrated the chemoselective 
functionalisation of the particles in addition to non-covalent drug loading.
140
 
Polymeric particles containing azide or alkyne and carboxyl functionalities have also 
been reported and successfully modified.
141
 Azide-functionalised particles have been 
prepared by reversible addition/fragmentation chain transfer polymerisation (RAFT) 
with the agents subsequently functionalised via Michael addition and azide groups by 
Huisgen cycloaddition.
142
   
Recently, a variety of palladium-mediated metal-catalysed reactions have been 










(Figure 4.2). The Suzuki-Miyaura cross-coupling has even been performed inside 
cells
149
 and for directly labelling bacteria in vitro.
150
 
In this chapter the preparation of novel dual-functionalised polymeric particles 
containing aminomethyl and boronic acid groups are reported. These particles offer 
the ability to chemoselective functionalisation via amide bond formation and/or 
Suzuki-Miyaura cross-coupling. 





Fig. 4.2. Palladium-mediated protein functionalisation. 
 
4.2 Boronic acid particles and Suzuki-Miyaura cross coupling  
PARTICLE SYNTHESIS. The attachment of molecules via palladium-mediated 
Suzuki-Miyaura cross coupling requires the incorporation of either an aryl boronic 
acid or aryl halide functionality into the particle structure. Previously, polymers 
functionalised with boronic acid have been prepared to investigate their behaviour 
towards external stimuli. Kataoka prepared a hydrogel containing boronic acid 
groups whose swelling was induced by glucose to release insulin.
151
 This technique 
was also used to detect glucose by viscosity measurements.
152
 A further feature of 
boronic acid polymers is their ability to self-assemble into particles
153
 and 




disassemble following a glucose or pH stimulus.
154
 Based on this boronic acid 
functionalised polymers, the effects of co-polymerising para-vinylbenzylboronic 
acid 44 (VBA) with styrene 2, divinylbenzene 3 (DVB) and para-vinylbenzylamine 
hydrochloride 1 (VBAH) was investigated (Scheme 4.2).  
 
Scheme 4.1. Synthesis of boronic acid- and aminomethyl-functionalised polystyrene-
based polymeric particles for Suzuki-Miyaura-mediated attachment. 
 
The particles were prepared by an emulsifier-free emulsion polymerisation of 
styrene 2, cross-linker dinvinylbenzene 3 (2%), para-vinylbenzylamine 
hydrochloride 1 (3%) in water using the water soluble radical initiator V-50. To 
investigate the effects of the incorporation of (HO)2B-functionalities onto the particle 
surface, varying amounts (3% 45, 6% 46 and 9% 47) of VBA were included and 
compared to (HO)2B-free particles 4d (Table 4.1). These had a size of 230 nm and a 
polydispersity index (PDI) of 0.060 demonstrating a monodisperse distribution and 
spherical morphology in addition to aminomethyl functionalisation (82 µmol/g). The 
addition of VBA resulted in a similar size distribution (240 nm) which was also 
classified as monodisperse with a PDI of 0.071. Scanning electron microscopy 
images verified these results and showed the spherical morphology of these particles 
45 (Figure 4.2). These results are in accordance with the ability to co-polymerise 




fluorescein-based monomers, without detrimental effects on the quality of the 
particle dispersion (Chapter 3).
126
 
A further increase in VBA led to a degradation of the particle quality, although 
the size was still in the 200 nm range. The polydispersity was determined to be 0.190 
for 6% VBA and 0.313 for 9% VBA. The rational for this is probably due to an acid-
base interaction between VBAH and VBA which disturbed micelle formation thus 
lowering the quality of the required micelles in which the particles were formed 
(Table 4.1 and Figure 4.2).
50
    
   
Table 4.1. Influence of VBA concentration on particle properties. 
Particles Size [nm] (PDI) H2N-Group [µmol/g] (HO)2B-Group [µmol/g] 
4d (0% VBA) 229 (0.060) (82 ± 14) (2 ± 1) 
45 (3% VBA) 240 (0.071) (129 ± 15) (62 ± 1) 
46 (6% VBA) 260 (0.190) (163 ± 5) (116 ± 2) 

































Fig. 4.2. Comparison of particles co-polymerised with para-vinylbenzylboronic acid 
(4d: 229 nm, PDI: 0.060; 45: 240 nm, PDI 0.071; 46: 260 nm, PDI 0.190; and 47: 
211 nm, PDI: 0.313. Scale bar equals 2 µm). 
 
In addition to the size and morphology of the particles, verification of the surface 
functionalisations was essential to validate their potential for use in various 















 and was compared to (HO)2B-free particles 4d (80 µmol/g). Similar loadings 
were found for (HO)2B/H2N-particles (80-130 µmol/g) (Table 4.1). Loading 
fluctuations were also observed following the synthesis of different (HO)2B-free 
particle batches. To quantify the amount of incorporated boronic acid groups, the 
particle dispersion was directly analysed by inductively coupled plasma – optical 
(atomic) emission spectroscopy (ICP-OES).
155
 In principal, the dispersion is 
nebulised and transferred into the plasma where it decomposes into its atomic 
constituents. As expected, particles prepared without the addition of VBA did not 
contain boron. However, particles prepared with 3% VBA contained approximately 
60 µmol/g boron which gradually increased to 120 µmol/g (6%) and 200 µmol/g 
(9%), respectively. This demonstrated that boronic acid was incorporated into the 
particles in a controlled manner and gave particles with boronic acid groups in 
addition to amino groups (Table 4.1).      
  Palladium-mediated conjugation. Palladium-mediated Suzuki-Miyaura cross 
coupling is a mild way to form carbon-carbon bonds. However, so far particle 
modifications by Suzuki-Miyaura cross couplings have not been reported. It was 
investigated if a palladium-mediated Suzuki-Miyaura cross coupling specifically 
takes place between (HO)2B/H2N-particles and an aryl halide. 5-iodofluorescein
126
 
35 was chosen as substrate to investigate the conjugation reaction. This compound 
enabled the Suzuki-Miyaura reaction to be followed via loss of the (HO)2B-
functional groups on the particle as well as fluorescence measurement of the particles 
after successful coupling.  




 reported a water soluble palladium 
catalyst for the palladium-mediated cross coupling and demonstrated the ability to 




functionalise iodinated proteins. The palladium catalyst 48 was prepared by 
basification of 2-amino-4,6-dihydroxypyrimidine 49 to give the sodium salt 50 
followed by addition of Pd(OAc)2 (Scheme 4.3a). The Suzuki-Miyaura cross 
coupling was carried out using a suspension of particles 45, 5-iodofluorescein 35 and 
palladium catalyst 48 in PBS at 37 °C (Scheme 4.3b). Herein, 50 equiv. of 5-
iodofluorescein were used in combination with a palladium catalyst concentration of 
5% with respect to the aryl halogene. 
 
 
Scheme 4.3. Suzuki-Miyaura cross coupling on polymeric particles: (a) synthesis 
of palladium catalyst with 2-amino-4,6-dihydroxypyrimidine ligand; and (b) Suzuki-
Miyaura cross coupling between 5-iodofluorescein and (HO)2B/H2N-particles. 
 
An analysis of the boron content of the suspension following the reaction 
demonstrated that particles 51 containing catalyst and 5-iodofluorescein showed an 
approximately 40% reduction in boron content (Figure 4.3a). The boron levels in 
reactions containing non-iodinated fluorescein 52 and lacking catalyst 53 did not 
change in comparison to starting particles 45. Additionally, those results were 




confirmed by fluorescence intensities of the particles measured via flow cytometry 
(Figure 4.3b). Unmodified particles 45 had no significant fluorescent properties, but 
the fluorescence of particles 51 increased approximately 500-fold following 5-
iodofluorescein conjugation while the controls had only a slightly increased 
fluorescence probably due to non-specific adsorption of a small amount of 
fluorescein. Nevertheless, the loss of boronic acid and increase in fluorescence of the 
particles demonstrated that the specific Suzuki-Miyaura cross coupling reaction 
between 5-iodofluorescein and boronic acid had occurred on the particles.  
 
 
Fig. 4.3. Analysis of (HO)2B/H2N-particles following Suzuki-Miyaura cross 
coupling: (a) boron content by ICP-OES; and (b) fluorescence intensity of particles 
by flow cytometry. (45: unmodified (HO)2B/H2N-particles; 51: Suzuki-Miyaura 
cross coupled particles; 52: with non-iodinated fluorescein; and 53: without catalyst.) 
 
Further analysis of the reaction was carried out by varying the amount of the aryl 
halide. It demonstrated that 5 equiv. of the aryl halide were sufficient to conjugate 
approximately 50% of the boronic acid functionalities as analysed by ICP-OES. 
However, a further increase in 5-iodofluorescein concentration only slightly 
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at ~50 equiv. before decreasing, which was probably due to overloading and self-
quenching (Figure 4.4). 
   
 
Fig. 4.4. Concentration dependency of Suzuki-Miyaura cross-coupling reaction on 
solid particles (blue: boron content via ICP-OES; and red: fluorescence via flow 
cytometry).  
 
4.3 Cellular uptake and viability  
CELLUAR UPTAKE. In general, nano and submicron polymer particles are taken up 
by cells and they are therefore being used extensively as a cellular delivery 
platform.
53
 To investigate if the Suzuki-Miyaura reaction affects cellular uptake and 
viability following particle exposure, human embryonal kidney 293T cells 
(HEK293T) and human cervical cancer cells (HeLa) were exposed to 5-
iodofluorescein coupled particles 51. A gradual 14-fold increase in intracellular 
fluorescence was observed with rising particle concentration. This demonstrated the 
successful internalisation of the coupled particles (Figure 4.5, external cellular 
fluorescence was quenched by addition of 2% trypan blue
156
); with a loading of 75 
µg/mL sufficient to fluorescently label more than 95% of the cells. These results 


























































Fig. 4.5. Cellular uptake of fluorescein-functionalised particles 51: (a) HEK293T 
cells; and (b) HeLa cells. (24 h uptake followed by 24 h recovery prior analysis by 
flow cytometry; n = 3). 
 
 
Fig. 4.6. Microscopy images following uptake of fluorescein-functionalised particles 
(50 μg/mL, 24 h): (a) HEK293T cells; and (b) HeLa cells. (i) bright-field; (ii) green: 
fluorescent particles 51 (λex = 488 nm); (iii) blue: nuclei stain Hoechst 33342 (λex = 
405 nm) and (iv) overlay. Scale bar = 100 µm. 
 
CELL VIABILITY. The attachment of bioactive compounds by Suzuki-Miyaura 
cross coupling requires palladium which is known to have adverse side effects on 
cell viability.
157
 However, following 5-iodofluorescein conjugation and washing, a 
palladium concentration of only 0.04 nM by ICP-OES was detected at a particle 
concentration of 75 µg/mL. To investigate if palladium treated particles had a toxic 
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The assay, which used 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), is based on the conversion of a yellow tetrazolium derivative into a 
purple formazan dye by reducing enzymes produced only by viable cells.
158
  
The assay revealed that the cellular internalisation of the particles (up to 75 
µg/mL) had no influence on cell viability (Figure 4.7). These results demonstrated 
that the Suzuki-Miyaura conjugation enables the attachment of molecules to 
(HO)2B/H2N-particles which are taken up by cells without adverse side-effects.    
 
 
Fig. 4.7. Cell viability following internalisation of fluorescein-functionalised 
particles 51: (a) HEK293T cells; and (b) HeLa cells. (24 h uptake followed by 24 h 
recovery prior analysis by flow cytometry; n = 3).   
 
4.4 Dual-functionalisation of particles  
The particles were shown to be able to conjugate molecules by Suzuki-Miyaura 
cross coupling using the boronic acid functionalities. In addition to this functionality 
the particles also bear aminomethyl groups which can be used for coupling of 
molecules via amide bond formation. The two conjugation methods are orthogonal to 
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the same particle. To investigate the potential of the dual-functionalised particles, 
subsequent conjugation of two different molecules onto the particle surface was 
investigated.      
DUAL-FUNCTIONALISATION. The ability to display two molecules on one particle 
by subsequent use of amide bond formation and Suzuki-Miyaura cross coupling was 
investigated by the preparation of a fluorescein-based sensor. The concept was based 
on a polymeric particle for cellular internalisation and sensing. A stimuli-dependent 
turn-on fluorescent probe (fluorescein-based sensor) and an additional fluorophore  
to quantify the cellular uptake (cyanine 5) were conjugated onto the particles. The 
probe would contain fluorescein in close proximity to methyl red separated by a 
cleavable disulphide linker. If both dyes are in close proximity, the fluorescent 
output of fluorescein is absorbed by methyl red.
159
 However, following cellular 
uptake the disulphide bond is cleaved and fluorescein is released from the particle, 
diffuses into the medium and its fluorescent signal can be detected. The disulphide 
bond is a stable bond in an extracellular environment but is reduced and cleaved in 
the cytosol due to the presence of reducing agents such as glutathione.
160
 Therefore, 
the release of fluorescein would indicate the successful delivery into the cell, and 
moreover, demonstrate the reducing environment inside the cell. In addition the 
particles were labelled with the fluorophore cyanine 5 (Cy5) which is excited in the 
orange region of the visible light spectrum and emits in the far red region. Hence, the 
signal is neither influenced by methyl red nor fluorescein and can be used to quantify 
the internalisation of the particles. Furthermore, the fluorescein part of the construct 
can be labelled with an additional molecule carrying a targeting sequence or 
bioactive cargo, whose release can be verified by fluorescein emission. In this proof 




of concept study, the cargo was composed of an anionic peptide to avoid membrane 
leakage of the cleaved fluorescein (Figure 4.9a). 
The fluorescein methyl red conjugate was synthesised by standard 
fluorenylmethoxycarbonyl (Fmoc) solid phase chemistry on Rink amide polystyrene 
resin prior to attachment to the polymeric particle (Scheme 4.4).
161
 The molecule was 
built up in a C- to N-direction starting with the conjugation of Fmoc-protected 
aspartic acid to the Rink amide linker 54. Following Fmoc-deprotection, another 
aspartic acid was attached and the cycle repeated with glycine and aspartic acid until 
attachment of the Fmoc-Lysine(Dde)-OH (55). The introduction of 5(6)-
carboxyfluorescein on the side-chain was achieved by Dde-deprotection of the ε-
amino group of Lysine under orthogonal Fmoc-conditions
162
 and subsequent 
fluorescein coupling (56). Following the attachment of 5(6)-carboxyfluorescein, the 
Fmoc-group of Lysine was deprotected and the synthesis completed with attachment 
of the disulphide linker, Fmoc-Lysine(Dde)-OH, aminohexanoic acid and para-
iodobenzoic acid. The Dde-protected ε-amino group of Lysine was deprotected and 
subsequently coupled to methyl red (57). As a control, 58 a molecule containing two 
non-cleavable aminohexanoic acids instead of the disulphide linker was prepared.  





Scheme 4.4. Synthesis of fluorescent turn-on probes.  




The particle’s amino groups were conjugated to carboxylated Cy5 59 using 
oxyma/DIC [60] followed by Suzuki-Miyaura cross coupling of the fluorescein 
quencher probe 61 (disulphide-linker) and 62 (Ahx-linker) (Scheme 4.5). Successful 
Cy5-coupling was verified by flow cytometry with a 10,000-fold increasing Cy5-
fluorescence while attachment of the fluorescent probe was determined by ICP-OES 
and showed a reduced boronic acid concentration (disulphide-linker 61: 77%; Ahx-
linker 62: 60%). 
 
 
Scheme 4.5. Orthogonal attachment of Cy5 and fluorescein-based probe onto dual-
functionalised polymeric particles.  
 
The ability to cleave the disulphide linker and release fluorescein from the particle 
was investigated by chemically induced cleavage with dithiothreitol (DTT) in PBS 
buffer (pH 7.4). The fluorescence emission of the supernatant was measured before 




and after DTT-treatment, and significant fluorescence intensity was only detected for 
the disulphide-linked particles 61 after DTT-treatment which verified the cleavage of 
the disulphide bond and the release of fluorescein (Figure 4.8). In contrast, no 
fluorescence signal was detected following DTT treatment of aminohexanoic acid 
linked fluorescein on particles 62.   
 
 
Fig. 4.8. DTT-induced cleavage of the fluorescein quencher probe (fluorescence 
spectra of supernatant. λex = 488 nm in PBS (pH 7.4); blue: disulphide-linker 61 
before DTT-treatment; green: Ahx-linker 62 before DTT-treatment; red: disulphide-
linker 61a after DTT-treatment; and purple: Ahx-linker 62a after DTT-treatment.). 
 
Following the successful dual conjugation of Cy5 and fluorescein-based probes 
onto the particles and additional verification of the release of fluorescein following 
disulphide bond cleavage, an investigation of the intracellular behaviour was carried 
out. HEK293T and HeLa cells were exposed to varying particle concentrations for 24 
h followed by replacement of the medium and 24 h recovery period to allow 
disulphide bond cleavage to occur (Figure 4.9). Since, the fluorescence of Cy5 is 
































61   
62a  
62  




intracellular particle concentration (blue). The uptake was identical for disulphide 61 
(dark shade) and aminohexanoic acid 62 (light shade) modified particles, however 
the fluorescein fluorescence (green) changed depending on the linker, with a linear 



























Fig. 4.9. Fluorescent analysis of cells following the internalisation of the fluorescein-
based probe containing a cleavable disuphide-linker (61) or non-cleavable Ahx-linker 
(62): (a) fluorescein release and fluorescence turn-on following cellular 
internalisation; (b) Cy5-fluorescence of HEK293T cells; (c)  fluorescein fluorescence 
of HEK293T cells; (d) Cy5-fluorescence of HeLa cells; (e) fluorescein fluorescence 
of HeLa cells. (24 h uptake followed by 24 h recovery. Extracellular fluorescence 
was quenched by addition of 2% trypan blue.
156
 Light shade: non-cleavable Ahx-
linked particles (62); dark shade: cleavable disulphide-linked particles (61). n = 3.) 
 
Fluorescence microscopy images of the cells were taken to verify the cellular 
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4.10). The nuclei and cytoplasm of HEK293T and HeLa cells were stained with 
Hoechst 33342 and celltracker red, respectively, to identify the location of the 
particles and fluorescein. Both disulphide-linked 61 and Ahx-linked 62 particles were 
located in the cytoplasma outside the nucleus in both cell lines. However, a 
fluorescein signal was detected from the disulphide-linked particles co-localised with 
the cytosol stain celltracker red verifying the release of fluorescein from the particles 
into the cytosol. In contrast, no fluorescein signal was detected in cells after exposure 
to Ahx-linked particles demonstrating that fluorescein remained in close proximity to 
methyl red and attached to the particles.     
These results demonstrated the successful preparation of the particle-based probe 
using amide bond formation and Suzuki-Miyaura cross coupling for orthogonal 
attachment of two functional molecules and thiol-mediated cleavage of the cargo 
from the particles. 
 





Fig. 4.10. Fluorescence microscopy images of internalised particles and release of 
fluorescein into the cytosol: (a) disulphide-linked particles 61 in HEK293T cells; (b) 
Ahx-linked particles 62 in HEK293T cells; (c) disulphide-linked particles in HeLa 
cells; and (d) Ahx-linked particles in HeLa cells. (i) Blue: nuclei stain Hoechst 33342 
(λex = 404 nm, λem = 414-483 nm), red: cytosol stain celltracker red (λex = 594 nm, 
λem = 600-628 nm); ii) magenta: Cy5-labelled particles (λex = 633 nm, λem = 642-750 
nm); iii) green: released fluorescein (λex = 488 nm, λem = 497-586 nm); and iv) 
composite image. Bar equals 50 µm.   
 
4.5 Conclusion 
The desire to improve conjugation methods in particular by milder and 
(bio)orthogonal routes compatible with the biological milieu are much sought aften. 
Herein, novel boronic acid functionalised particles were prepared and their ability to 
conjugate bioactive cargos in a palladium-mediated Suzuki-Miyaura fashion was 
demonstrated. The particles were proven to be efficiently taken up by cells without 




toxic side-effects, furthermore, the particles contained additional amino groups for 
the direct-on-particle dual-functionalisation via amine-based and Suzuki-Miyaura 
methodology. As a proof of concept, a fluorophore was attached to the particles by 
amide bond formation and a cleavable fluorescein-based probe was subsequently 
attached on the particles by palladium-mediated coupling. The particles were 
internalised into cells and a fluorescein-based signal was successfully detected in the 
cytoplasm. This novel route of palladium-mediated particle conjugation increases the 
number of bioorthogonal methods to functionalise particles. In addition, the 
availability of the amino group on the particle allows the dual-functionalisation that 
is required by an increasing number of applications.  
The bioconjugation technique might be further improved by identifying 
conditions to replace palladium, e.g. by iron.
163
 Moreover, the ability to genetically 
encode aryl halides into proteins would allow site-specific attachment of proteins 
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5.1 Particles and their behaviour in biological systems  
The technology of engineered nanomaterials is considered to be one of the most 
promising developments of the near future. It is expected that nanotechnology will 




 but also on 
day-to-day consumer products.
166
 Although nanoparticles originate naturally during 
forest fires and volcanic events, 
167
 it is thought that human exposure to nanoparticles 
will dramatically surge over the next decade due to the increased output of novel 




anthropogenic nanomaterials. Therefore, a general and thorough understanding of the 
behaviour of nanoparticles in biological systems is necessary such an understanding 
includes the characterisation of nanoparticles after they have contacted biological 





5.2 Adsorption of biomolecules onto particles  
BIOMOLECULE ADSORPTION. A biological milieu surrounds most of the cells in 
an organism and supplys them with nutrients. The concentration and composition of 
these nutrients is dynamic but it is generally composed of a wide variety of proteins, 
lipids and sugars. Particles designed to have cell-based applications are initially 
introduced into this fluid often resulting in the adsorption of the biomolecules present 
onto the particle’s surface. It is this “particle-biomolecule” construct that approaches 
and contacts a cell prior uptake.
169
 The formation and composition of those 
constructs might influence the particle’s cellular uptake and toxicity.
170
      
The biomolecule layer or corona on the particle’s surface is formed immediately 
upon dispersion of the particles in the biological fluid (Figure 5.1).
171
 At first, highly 
abundant biomolecules, e.g. serum albumin, adsorb quickly onto the particle’s 
surface. However, these are not necessarily the molecules with the highest affinity, 
and may be displaced over time with stronger binding but less abundant 
molecules.
172
 A distinction can also be made between so-called soft and hard 
coronas. Molecules in the soft corona are attached with low affinity to the particle 
surface and have a short residence time with high and dynamic exchange rates in 




contrast to biomolecules in the hard corona.
173
 Indeed, the corona is by no means a 











Fig. 5.1. Formation of the biomolecule layer (corona) on the particle surface.  
 
The composition of the particle’s corona depends on both the availability of 
biomolecules, and the particle’s properties. It has been shown that the corona is 
mainly composed of proteins
175





 In general, proteins present in large quantities in serum or media such 
as immune and transport proteins are located on particle surfaces.
178
 However, even 
proteins of low abundance, identified in small quantities on particles, can play an 
important role in cell-particle interactions,
179
 and proteins on the corona are 
internalised when particles are taken up by cells.
180
 The adsorption of proteins on the 
particle surface can induce conformational changes as well as biological activity 
including the generation of aberrant immuno responses.
181
  
The influence of particle properties on the composition of the protein corona is 
not completely understood. However, surface characteristics such as chemical 
Biomolecules    KD, Soft Corona >> KD, Hard Corona 
Dynamic Exchange with 
















functionality, charge, hydrophobicity, heterogeneity, porosity and curvature
182
 appear 
to be more important than particle size and core composition. This effect can be 
explained by the high surface to volume ratio of nanoparticles which amplifies the 
characteristics of the surface. In addition, after the formation of the protein corona, 
the transformed surface can also affect the dispersion stability of the polymeric 
particles.
183
    
In summary, the introduction of particles into biological fluids is followed by an 
almost immediate formation of a corona surrounding the particles. The composition 
and structure of the corona is determined by the particle’s surface and generates the 
first point of contact between the particle and the cell. However, so far no clear 
paradigms have been established to predict the composition of the corona, thus, the 
effects of variously functionalised particles on the composition of the protein corona 
was investigated.  
PARTICLE’S SURFACE CHEMISTRY AND THE PROTEIN CORONA. Aminomethyl-
functionalised polystyrene-based particles 4a were synthesised and subsequently 
modified to generate particles with identical cores and sizes but different surface 
properties (Chapter 2) to investigate its influence on the protein corona. The 
properties were dependent on the modifications applied and included anionic 
(sulphonated 10 (SO3) and carboxylated 9 (COOH)), neutral (hydroxylated 63 (OH), 
acetylated 16 (NHAc), zwitterionic 12 (ZI), Fmoc-PEGylated 15 (Fmoc-PEG)) and 
cationic (guanidinium 8 (Gd) and amino 4a (NH2)) surface groups (Figure 5.2). 
 





Fig. 5.2. Surface-varying polystyrene-based particles (see also Chapter 2). 
  
The particles were characterised by their zeta potentials in phosphate-buffered 
saline at pH 7.4 (Figure 5.3a, see also Chapter 2) and also in an acidic environment 
(saline at pH 5.6) (Figure 5.3b). Zeta potentials for the anionic (9 and 10) and 
cationic particles (4a and 8) were determined to be negative and positive, 
respectively, in an acidic and basic environment. Neutral particles (12, 15b, 16 and 
63) were measured as having a potential close to zero mV in a basic environment. In 
an acidic mileu a strong positive zeta potential was determined for PEGylated 
particles 15 (+20 mV), while zwitterionic particles 12 had a strongly negative zeta 
potential of -25 mV. Zeta potentials of acetylated 16 and hydroxylated 63 particles 
were close to zero mV in an acidic environment. To investigate the influence of 
FmocHN-PEG (15b) 




biological fluids, particles were dispersed in medium containg 5% serum followed by 
zeta potential measurements (Figure 5.3c). A zeta potential of -12 mV was 
determined for all particles independent of surface functionalisation. The collapsed 
zeta potential indicated the formation of a protein corona. It has been shown 
previously that particles with different surface functionalities have similar zeta 
















Fig. 5.3. Particle’s zeta potential and its dependency on surface chemistry and 
dispersion medium: (a) PBS (pH 7.4); (b) saline (pH 5.6); (c) cell culture medium 
supplemented with 5% serum; and (d) artificial lung-lining fluid (LLF). 10 (SO3); 9 
(COOH); 63 (OH); 16 (NHAc); 15 (Fmoc-PEG); 12 (ZI); 8 (Gd); and 4a (NH2). 
 
To further investigate the protein corona, a quantitative and qualitative 
determination of the proteins in the corona was carried out. Thus, particles were 
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fetal bovine serum (FBS) for 2 h, followed by extensive washing to remove weakly 
binding proteins. Proteins were detached by boiling the particles in 4% aqueous 
sodium dodecyl sulphate (SDS) and subsequently analysed via SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) and mass spectrometry. Figure 5.4 shows the 
composition of the protein corona with respect to the particle’s surfaces. In general, 
protein coronas found on different particle surfaces were composed of similar 
proteins in similar ratios but differed from the protein distribution of the medium. 
Highly abundant proteins in the media (lane 1) were mainly detected on the particle’s 
surfaces. In particular, bovine serum albumin (BSA) (band e) was the most abundant 
protein on all particle surfaces independent of their chemical nature.
185
 BSA is a 
highly abundant protein in serum as well as having a high natural affinity to a broad 
variety of surfaces.
186
 However, the abundant serotransferrin was only detected in 
very low concentrations on the particle surfaces despite having the second highest 
occurrence in the medium. Further proteins identified in the protein corona belong 
largely to the groups of transport proteins such as α2-macroglobulin and 
apolipoprotein. These results were in accordance with equal zeta potential values 
determined for particles in protein-containing media. The zeta potential values are 
mainly influenced by the surface chemistry of the particles, thus the formation of a 
similar protein corona independent of the particle’s surface chemistry masked these 
















Fig. 5.4. SDS-PAGE analysis of particles following exposure to serum. Lanes: (i) 
serum; (ii)  reference protein serine palmitoyltransferase (B. fragilis, 5.4 µg, M = 44 
743 g/mol; (iii) 4a (NH2); (iv) 8 (Gd); (v) 15 (Fmoc-PEG); (vi) 9 (COOH); (vii) NiO 
nanoparticles; (viii) 63 (OH); (ix) 16 (NHAc); (x) 10 (SO3); (xi) 12 (ZI); and Co3O4 
nanoparticles (xii). Bands: (a) α2-macroglobulin; (b) inter-α-trypsin inhibitor; (c) 
complement factor B; (d) serotransferrin; (e) serum albumin; (f) actin; (g) 
adiponectin; (h) apolipoprotein; (i) haemoglobin; and (j) haemoglobin subunit.  
 
In conclusion, a relationship between surface functionalisation of particles and the 
composition of the protein corona was not established. The protein corona 
composition was mainly affected by proteins in the dispersion medium which were 
adsorbed equally on different particle surfaces.  
 
5.3 Surface-modification and its influence on cellular uptake 
 CELLULAR UPTAKE OF PARTICLES. The ability of nano and submicron particles 
to cross the cell membrane has long been established
25
 and this phenomenon has 
been exploited in a variety of biomedical applications such as cellular delivery, 
intracellular sensing and cellular trafficking.
187
 Furthermore, nanoparticles have been 
shown to be internalised in a wide variety of phagocytotic
188
 and non-phagocytotic 
cell lines.
189
 However, a detailed understanding of particle uptake into cells is 
lacking, in particular the dependency of uptake on the particle’s surface properties 














and the differences between cell lines. Particle size, surface chemistry and charge 
seem to be the most important
80,190




It has been shown that the manipulation of a particle’s characteristics influence 
uptake by cells. The presence of surface charge on particles increases the uptake of 
whether they are positively or negatively charged.
124,189
  Presumably, positively 
charged particles are attracted by the negatively charged cell membrane while the 
trafficking of negatively charged particles might be governed by the protein corona. 
In comparison, the positive charge seems to further increase the uptake of 
particles.
192
 Moreover, particle uptake is influenced by particle size with smaller 
sizes being taken up in larger quantities.
193–195
 In addition, particle size also 
determines the uptake mechanism although surface charge also influences this.
196
 In 
general, a clathrin-dependent endocytotic uptake has been implicated for particles 
below a diameter of 200 nm while bigger particles are predominantly taken up by 
caveolae-dependent endocytosis.
196,197
 However, it has been shown that non-
phagocytotic cells can also internalise particles via a passive mechanism, with 
anchoring to the extracellular membrane followed by the particle “puncturing” 
through into the cytosol.
193,198
  
Moreoever, it is clear that formation of a protein corona “masks the particle’s 
surface” in solution, but the “pristine surface’s properties” are presumably exposed 
following the contact with the cell membrane and influence the uptake into cells. 
Furthermore, the composition of the protein corona could additionally influence 
particle uptake.
199,200
    




The recently investigated effects of particle properties on cellular uptake 
demonstrate that a simple prediction of uptake efficiency is difficult. In addition, 
uptake data vary between cell lines. However, particular particle characteristics such 
as surface chemistry, charge and size all seem to influence the uptake despite the 
formation of the corona. To maximise the potential of intracellular particle-based 
applications, the ability to design particles for efficient cellular uptake is neccessary 
and key to this is an understanding of surface group influences.  
CELLULAR UPTAKE. To investigate the influence of the particle surface and its 
protein corona on cellular uptake, fluorescent aminomethyl-functionalised 
polystyrene particles 40b were synthesised via co-polymerisation of styryl 
fluorescein
126
 (Chapter 3) and subsequently modified to give various surface groups; 
anionic (sulphonated 64 (SO3) and carboxylated 65 (COOH)), neutral (hydroxylated 
66 (OH), acetylated 67 (NHAc), zwitterionic 68 (ZI)) and cationic (guanidinium 69 
(Gd), PEGylated 70 (H2N-PEG) and amino 40b (NH2)). The modifications of the 
particle’s surfaces were carried out using identical conditions as described for non-
fluorescent particles (Chapter 2). As shown above, the composition of the protein 
corona was not affected by the particle’s surface chemistry and seemed to mask the 
surface.  
To investigate if the surface chemistry influences even when masked by a corona, 
particle uptake, the particles were incubated with human cervical cancer cells 
(HeLa). The uptake was carried out in cell culture media containing DMEM 
supplemented with 10% FBS for 24 h. The particle uptake was quantified by 
determination of the fluorescence of the cells correlating with the level of 
internalised fluorescently labelled particles (Figure 5.5). Positively charged particles 




were taken up by cells in higher quantities in comparison to neutrally or negatively 
charged particles. These results suggested that the surface charge of the particles 
dominates the ability to be internalised rather than the protein corona composition 
which was independent of surface functionalisation. Similar results have been 
established previously.
201,202
 However, surprisingly particles functionalised with a 
PEG-spacer linked amino group 70 were taken up much more rapidly than amino-











Fig. 5.5. The influence of surface functionalisation on the cellular uptake of 
fluorescent particles in HeLa cells (24 h; n = 3). 
 
Further analysis of cellular uptake and particle surface chemistry was carried out 
by studying the influence of the attached spacer while maintaining the terminal 
amino group. This was achieved by using combinations of aminohexanoic acid and 
H2N-PEG3-OH as spacers (Figure 5.6). The particles were prepared following 









































spacer and all had a positively charged surface determined by zeta potential analysis 
(Table 5.1). The effect of adsorbed proteins onto the particle’s zeta potential was 
investigated; incubation with medium supplemented with 10% serum resulted in zeta 
potentials of approximately -20 mV which was independent of spacer length, thus 
demonstrating the formation of protein coronae.    
Fig. 5.6. Amino-functionalised fluorescent particles with varying spacer length.  
 
Table 5.1. Particle’s zeta potential and its dependency on dispersion medium. 
Particle Zeta Potential 





40b (+46.0 ± 0.1) mV (-23.7 ± 1.7) mV (-3.5 ± 2.1) mV  
71 (+46.3 ± 2.5) mV (-22.6 ± 1.6) mV (-6.5 ± 1.2) mV 
72 (+23.2 ± 1.1) mV (-21.2 ± 1.3) mV (-7.6 ± 0.2) mV 
43b (+27.5 ± 1.1) mV (-17.6 ± 1.3) mV (-5.4 ± 1.0) mV 
73 (+36.2 ± 1.9) mV (-18.5 ± 0.7) mV (-4.1 ± 0.9) mV 
74 (+13.1 ± 2.8) mV (-18.8 ± 1.9) mV (-7.0 ± 0.1) mV 
 




The cellular uptake of the particles was investigated in HeLa cells in 10% serum 
supplemented medium. To emphasise the differences between the particles, the 
uptake time was reduced to 2 h (Figure 5.7, red columns). As can be seen the 
attachment position of the amino group significantly influenced particle 
internalisation. A small distance to the particle surface (one atom 40b and eight 
atoms 71) resulted in good uptake, however, the particle uptake increased 5-fold if a 
15-atom spacer (72) was used instead. If the spacer was further extended (20-atoms 
(43b), 27-atoms (73) and 39-atoms (74)), particle uptake dropped back down to the 
level of the short spacers (40b). These results verified that the surface characteristics 











Fig. 5.7. Cellular uptake in HeLa cells of amino group functionalised particles with 
varying spacer length. Cellular uptake in serum/DMEM (red) and cellular uptake in 
low-protein medium (blue). (Uptake 2 h; n = 3). 
 
As demonstrated, varying spacer length influenced cellular internalisation of the 
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ratios. Thus it appears that the spacer influences particle uptake while the influence 
of the adsorbed proteins is marginal. To further investigate this theory, the various 
amino-functionalised particles were analysed in reduced-serum medium. This 
decreases the amount of adsorbed proteins, hence, amplifying the spacer 
characteristics. Reduction of the protein content resulted in zeta potentials of -5 mV 
for all particle surfaces although functionalised with different length spacers (Table 
5.1). A SDS-PAGE revealed that the composition of the corona was identical for 
different spacer functionalised particles and mainly consisted of serum albumin 
(Figure 5.8). However, in comparison to medium supplemented with 10% serum, 
particles had less protein bound.   
 
     
Fig. 5.8. Composition of the protein corona on particles with varying spacer length in 
low-protein medium. Lanes: (i) protein-ladder; (ii) reduced-serum medium; (iii) 1-
atom (40b); (iv) 8-atoms (71); (v) 15-atoms (72); (vi) 20-atoms (43b); (vii) 27-atoms 
(73); (viii) 39-atoms (74). Bands: (a) serum albumin.   
 
The cellular uptake pattern of the particles under these conditions was identical in 
comparison to the 10% serum incubated particles; the most efficient uptake was 
observed for particles carrying a “15-atom” and “20-atom” spacer while it decreased 
(i)               (ii)         (iii)    (iv)     (v)     (vi)    (vii)    (viii) 
(a) 




for shorter or longer spacer lengths. Achieving the same results in low-protein 
medium, suggests that the spacer influences cellular uptake rather than the protein 
corona.  
These studies demonstrate that the spacer length can be used to tune cellular 
uptake. The spacer on the particles probably influences this by acting as an anchor 
group which improves binding. Herein, the anchor supports an interaction between 
the particle and the biological surface, with protein coatings on the particle surface 
supporting attachment onto the cell membrane. A membrane-attached particle will 
then gain entry into the cell.
193
 The length of the spacer needs to be long enough to 
possess the flexibility to interact with the cellular membrane but also close enough to 
the particle’s surface that stable adsorbtion to the membrane surface is achieved 
(Figure 5.9). In fact, it has been shown previously that rougher surfaces promote 
protein binding,
203,204
 hence, explaining the advantages of a defined spacer length for 







Fig. 5.9. Proposed spacer-dependent interaction with the cell membrane: (i) particle 
with adsorbed proteins approaches cell membrane; (ii) spacer groups on the particle 
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5.4 Surface-modification and its influence on cellular toxicity 
TOXICITY OF PARTICLES.  In developing particle-based applications, the effects 
on human health have to be taken into consideration. In fact, a number of different 
particles have been shown to have adverse side-effects.
205
 However, not all nano and 
submicron-sized particles are toxic and so far extensive in vitro and in vivo studies 
have yet to be carried out to identify the risk of different types of particles.
206
 
A general source of potential hazardousness is based on the behaviour of such 
material towards cells which can be summarised by three principles.
167
 Firstly, the 
transport principle defines the ability of nanoparticles to uncontrollably enter cells 
and to dissolve or degrade releasing further possible harmful fragments. Secondly, 
the surface principle describes the large surface area to volume ratio of the particles 
generating high reactivity which is potentially harmful and thirdly, the material 
principle states that particles of the same composition can behave differently 
depending on their size.
167
  
The liberation of nanoparticles into the environment and their exposure to humans 
is not new. Nanoparticles originate from natural process such as forest fires, 
volcanoes and nature, including pollens and viruses; however the number and variety 
of particles has increased dramatically over the last decades. To date the main route 
of nanoparticle uptake into humans is via the lung, while oral and dermal uptake is 
considered to be low due to the protection offered by the gastrointestinal tract and 
skin, respectively. In future, the uptake by direct injection into the blood stream 
might grow due to the field of nanomedicine.
167
 Moreover, administered 
nanoparticles might be distributed throughout the body by the bloodstream
207,208
  or 
even cross the brain blood barrier.
209
       




On a cellular and molecular level, particles have been shown to induce oxidative 
stress by forming reactive oxygen species (ROS). ROS formation results from the 
high surface area and associated high reactivity of the particles. This reactivity can 
lead to potential interference with the redox system of cells as well as activation of 
neutrophils and macrophages leading to the production of an organism’s own 
ROS.
210
 For example, following the inhalation of combustion-derived particles into 
the lung, uptake by epithelia cells occurs with a potential interaction with cellular 
organelles (Figure 5.10). Once inside the cell, the particles are able to produce 
independent of their chemical composition or physical appearance, reactive oxygen 
species in a variety of ways. For example structural defects and metal impurities on 
the surface can chemically (e.g. redox chemistry) or physically (e.g. light) induce the 
formation of superoxide radicals which can lead to the oxidation of molecular 
components such as proteins, lipids and nucleic acids. This oxidative stress also 
initiates signal cascades which can lead to inflammation and eventually diseases such 
as asthma or lung cancer.
13,168,211





Fig. 5.10. Oxidative stress paradigm. 
 
Another route to the introduction of oxidative stress has been identified via 
membrane rupture. The damage of the membrane, in particular the lysosomal 
membrane,
212
 has been shown to release various cytotoxic and inflammogenic 
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 and has been used to detect the inflammogenic potential of 
particles.
217,218
 Although a positive surface charge could be the driving force leading 
to rupture,
182,219–222
 the relationship between surface charge and membrane rupture is 
not fully understood.  
The current major challenge of assessing nanoparticle risk is the development of 
assays to validate the toxicity of particles, preferably by in vitro means to reduce 
ethical and financial burdens.
223
 The design of those tests is closely linked to the 
identification of key physical and chemical parameters that result in adverse health 
effects. In addition, the above mentioned practical aims are extended by an 
understanding of toxicological mechanisms and their relation to particle properties 
such as composition, surface chemistry and size to name but a few.  In accordance 
with the surface characteristics and its influence on cellular uptake, it was likely that 
these properties would also affect the toxicity of particles. Due to the ever increasing 
importance of nanotechnology, it was desirable to identify key parameters to predict 
the toxic potential of particles. Furthermore, the knowledge of those parameters 
could allow specific modifications to reduce particle toxicity.  
SURFACE-FUNCTIONALISED PARTICLES. To further investigate the relationship 
between surface charge and the toxicity of particles, 200 nm aminomethyl-
functionalised polystyrene-based particles were synthesised and subsequently 
modified into anionic (sulphonated 10 (SO3) and carboxylated 9 (COOH)), neutral 
(hydroxylated 63 (OH), acetylated 16 (NHAc), zwitterionic 12 (ZI), Fmoc-
PEGylated 15 (Fmoc-PEG)) and cationic (guanidinium 8 (Gd) and amino 4a (NH2)) 
surface groups (Figure 5.2 and Chapter 2). The different behaviour of the particles 
towards cells is based on a different surface chemistry as all the particles were based 




on amino-functionalised precursor particles 4a. To evaluate the toxic potential of the 
particles these were also compared to metal oxide nanoparticles NiO ((92 ± 2) nm, 
zeta potential pH 7.4: -18.7 mV) and Co3O4 (185 ± 12) nm, zeta potential pH 7.4: -
30.1 mV).
218
 The determination of the zeta potential of the polymeric and metal 
oxide particles in medium supplemented with 5% serum revealed the formation of a 
protein corona (Figure 5.3c) of similar composition (Figure 5.4).  
STABILITY OF THE CORONA. To further investigate the effects of various surface 
groups and their protein corona, the particle’s behaviour with macrophages was 
studied. It has been shown previously that the corona is digested by lysosomal 
enzymes.
224
 The removal of the protein corona directly affects the zeta potential of 
the particles (Figure 5.3) and can lead to restoration of the primary charges. The 
behaviour of the protein corona in macrophages was modelled by incubation of the 
particles with lung lavage fluid and subsequent treatment with phospholipase A2 
(PLA2) (Figure 5.11a-b).
†
 To compare differently sized polymer and metal oxide 
particles, solutions were standardised by surface area and the phospholipids 
contained in the protein corona were quantified. Initially, all polymeric particles 
bound comparable amounts of phospholipids independent of surface 
functionalisation. However, significantly increased binding was observed on theses 
particles than on metal oxide particles (Figure 5.11a). Following exposure of the 
particles to enzymatic digestion, the amount of non-digested, attached phospholipids 
was determined (Figure 5.11b). The total amount of phospholipids adsorbed onto the 
polymeric particle surface exceeded the amount on metal oxide particles while 
sulphonated 10, hydroxylated 63 and Fmoc-PEGylated 15 particles had considerably 
                                                          
†
 Digestion assays were carried out by Dr Wan-Seob Cho at the Centre for Inflammation Research, 
University of Edinburgh. 




larger amounts of phospholipids bound to the surface than the other particles of the 
panel. Analysis also revealed that spacer length correlated with the amount of 
undigested phospholipids (Figure 5.11c). Interestingly, sulphonated 10 and 
hydroxylated 63 particles which contained aryl spacers were outside the linear 
correlation of alkyl-spacer functionalised particles. Presumably a strong hydrophobic 
and/or π-π interactions promoted phospholipid binding.  
These data suggest that the surface chemistry supports the retention of the corona 
by hindering access to the adsorbed biomolecules. In comparison to metal oxide 
particles, polymeric particles have a comparably rough surface with improved 
protection of the corona. Furthermore, the correlation between spacer length and 






































Fig. 5.11. Influence of enzymes on the phospholipid corona: (a) quantification of 
phospholipids on particles; (b) quantification of phospholipids on particles following 
PLA2 digestion; and (c) correlation between amount of phospholipid and spacer 
length (n = 4 and significance versus vehicle control: 
**
p  0.01, 
***
p  0.001. 10: 
SO3; 9: COOH; 63: OH; 16: Ac; 15: FmocHN-PEG; 12: ZI; 8: Gd; and 4a: NH2. 
 
HAEMOLYTIC ACTIVITY. To further study the impact of the surface 
functionalisation on the formation of a protein corona, particles were analysed for 
their ability to cause membrane rupture. A simple model to determine the ability to 
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potential of metal oxide particles correlates with haemolytic activity and lung 
inflammogenicity.
218
 If the particle’s zeta potential (as determined in saline at pH 
5.6) was less than +14 mV, no haemolytic potential was detected. However, it was 
demonstrated that an intact protein corona reduced the zeta potential and prevented 
haemolysis of the metal oxide particles. The stability of the corona on polymeric 




The haemolytic activity was determined with respect to triton X-100 (TX-100) in 
protein-free physiological saline.
225
 Negatively charged particles (SO3 10 and COOH 
9) and neutral particles (Ac 16 and FmocHN-PEG 15) did not induce haemolysis at 
30, 100 and 300 cm
2
/mL (Figure 5.12a). In contrast, positively charged (NH2 4a and 
Gd 8) ruptured the membrane at 100 cm
2
/mL or more. Haemolytic potential was also 
found for zwitterionic 12 and hydroxylated 63 particles at more than 100 cm
2
/mL. 
The haemolytic activity was found to be induced by particles with a zeta potential 









                                                          
‡
 Haemolysis assays were carried out by Dr Wan-Seob Cho at the Centre for Inflammation Research, 
University of Edinburgh. 











Fig. 5.12. Relationship of haemolytic activity and zeta potential: (a) haemolytic 
activity of particles at different surface area doses (significance versus vehicle 
control: 
***
 p  0.001. n = 4); and (b) correlation of haemolysis and zeta potential 
(particles were dispersed in saline, pH 5.6. Non-linear regression was applied. n = 4). 
10: SO3; 9: COOH; 63: OH; 16: Ac; 15: FmocHN-PEG; 12: ZI; 8: Gd; and 4a: NH2. 
 
However, the uptake of particles leads to formation of a protein corona prior 
cellular membrane contact. For example, particle inhalation by the lung exposes 
particles to lung lining fluid (LLF). This fluid contains a wide-variety of 
biomolecules which adsorb onto the particle’s surface and form a corona. To model 
pulmonic ingestion, polymeric particles (10: SO3; 9: COOH; 63: OH; 16: Ac; 15: 
FmocHN-PEG; 12: ZI; 8: Gd; and 4a: NH2) were incubated in artificial LLF and a 
surface independent zeta potential of -35 mV was determined for all particles (Figure 
5.3d). 
The protein corona and its effective reduction of the zeta potential has previously 
been shown to prevent haemolysis by metal/metal oxide particles.
218
 In fact, 
preincubation of particles with serum proteins or LLF medium prevented haemolysis 
of polymeric particles (Figure 5.13a). To evaluate the polymeric particles, NiO and 
Co3O4 particles were also included and identical effects were observed; the formation 
of a protein corona prevented haemolysis.     
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Fig. 5.13. Haemolytic activity of particles: (a) non-coronated and serum or LLF 
coronated particles; and (b) following incubation with the enzymes PLA2 and 
proteinase K and dispersion in saline. Significance versus vehicle control: 
***
 p  
0.001; n = 4. 
 
To analyse the effects of the intracellular presence of enzymes on haemolytic 
activity, preincubated particles were exposed to digestion enzymes PLA2 and 
proteinase K (Figure 5.13b). Metal oxide particles showed a restored haemolytic 
activity, in contrast, polymeric particles (ZI 12, FmocHN-PEG 15, NH2 4a, Gd 8) did 
not induce haemolysis. This implied that the corona was not completely removed 
from the polymeric material and the particle charges were still sheltered by the 
retained protein corona. 
In conclusion, under protein-free conditions, the zeta potential of polymeric 
particles (saline, pH 5.6) showed an excellent correlation with the lysis of human 
erythrocytes; higher zeta potentials lead to increased rupture of red blood cells.
214,215
 
However, in the presence of biomolecules a corona is formed that alters the zeta 
potential and the particles are non-lytic. Under the conditions found inside 
phagolysosomes a restoration of the prisitine particle surface can take place restoring 
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functional groups can promote protein stability hindering access to the proteins 
adsorbed on the particle surface. This protein corona shields the membranolytic 









Fig. 5.14. Model of influence of protein corona on toxicity of particles. 
 
5.5 Conclusion 
In contrast to the fast and extensive developments in the application-driven 
nanotechnology, the understanding of the behaviour of nanoparticles in biological 
systems is lacking. Herein, the contribution of the surface chemistry on the 
interactions with biological fluids and their implications for cellular uptake and 
toxicity were studied. Although, surface chemistry does not appear to significantly 
contribute to the composition of a protein corona, a positive surface charge facilitates 
the cellular uptake while uptake can be tuned by functionalisation with spacer 
molecules. These results imply that functionalisation could improve the 
internalisation of particles that would otherwise be poorly taken up.  
Coronated Inside the Cell 
Haemolytic Non-Haemolytic 
Haemolytic Non-Haemolytic Non-Haemolytic 
Metal Oxide  
(smooth surface) 
 Polymer Particle 
(rough surface) 
Haemolytic 




However, the formation of a protein corona masked the surface charge of particles 
which is associated with the inflammogenic properties of particles. In fact, the 
formation of a protein corona suppressed their haemolytic activity. The haemolytic 
potential could also not be restored by enzymatic digestion of the corona. The 
retained corona reduced the immediate surface-charge, thus shielding the 
membranolytic properties of the surface. Presumably, the surface roughness 
increased by attachment of a spacer hindering the enzymatic digestion of the corona 
on the particle’s surfaces. In contrast, comparable smooth metal oxide particles were 
unable to retain the protein corona and, thus, were found to be haemolytic following 
enzymatic digestion. 
Broadly based studies that investigate the influence of cellular uptake and toxicity 
are needed to improve the understanding of particle surface-cell-interaction. These 
studies should include various sized and functionalised particles as well as different 
cell types. The results could support the development of nanotechnology with 
particles fine-tuned to reduce toxicity, while promoting cellular internalisation.  
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6.1 General methods  
All chemicals were purchased from Aldrich, Acros or Fluka and used as received. 
Reactions involving moisture sensitive reagents were performed under positive 
pressure of dry nitrogen. The glassware used for these reactions was oven dried and 
cooled under dry nitrogen. Evaporation of solvents was performed at reduced 
pressure, using a Büchi rotary evaporator. Microwave-assisted heating was carried 




C nuclear magnetic resonance spectra were recorded on a Bruker DPX-
500 spectrometer (500 and 126 MHz respectively) at 298 K in deutered solvents. 
Residual protic solvents CHCl3 (H= 7.26 ppm, C= 77.0), CD2HOH (H= 3.30 
ppm, C= 49.0) and DMSO-d5 (H= 2.50 ppm, C= 39.5) were used as internal 
reference and peak position are reported as downfield shifts in parts per million () 
from TMS. Coupling constants were measured in Hertz (Hz). Resonances were 
characterised as singlet (s), doublet (d), doublet of doublet (dd), triplet (t), multiplet 
(m), or a broad singlet (bs).  
Chromatographic purification was performed on columns prepared with silica gel 
60-120 mesh. Analytical thin layer chromatography was performed using 
commercially available Silica gel F254 (Merck). The plates were visualized at 254 
nm and 344 nm wavelength or stained with ninhydrin (0.3% ninhydrin in n-butanol 




and 3% acetic acid) or permanganate solutions [(KMnO4 (3 g), K2CO3 (20 g), 5% 
aqueous NaOH solution (5 mL) and water (300 mL)].  
Low Resolution Mass Spectra (LRMS) were obtained using Hewlett Packard 
LCMS 1100 ChemStation with a G1946B mass detector. Reverse phase analytical 
HPLC (RP HPLC) was performed using an Agilent 1100 Chemstation on Supelco’s 
Discovery C18 (50 mm × 2.1 mm × 5 µm), and compounds were detected using an 
evaporative light scattering detector (ELSD) (Polymer Lab PL-ELS 1000 with 
detection at 220, 254, 260, 282, and 495 nm). All solvents used were HPLC grade.  
 96 well plates were analysed on a Benchmark Bio-Rad microplate reader at 570 
nm using the Microplate manager 4.0 software. 
SEM images were obtained on a Philips XL30CP SEM with PGT spirit X-ray 
analysis and a HKL channel Electron Backscatter Diffraction (EBSD) system on 
samples coated with a thin layer of gold, to a depth of approximately 20 nm, under 
vacuum. ICP-OES was performed on a Perkin Elmer Optima 5300 DV ICP-OES 
(detection limits: 0.0002-1000 ppm). Surface area measurements were carried out on 
a Micromeritics Gemini 2370 BET device. Centrifugation was performed on 
Eppendorf 5430R equipped with a fixed-angle rotor (Eppendorf, 45-24-11-HS). 
Fluorescence spectra were recorded on a SPEX Fluoromax, using a 1 cm path length 
with fused silica cuvettes. UV/Visible spectra were recorded on an Agilent 8453 
spectrophotometer using a 1 cm path length with fused silica cuvettes. Flow 
cytometry analysis was carried out on a Becton Dickinson (BD) FACSAriaTM using 
the FlowJo software for data analysis. Protein gels were imaged on a BioRad 
Laboratories Molecular Imager and processed with BioRad Laboratories Image Lab 
Software 3.0.  




Cell culture experiments were carried out in a HERAsafe KS 18 class II negative-
flow cabinet from Heraeus and in a HERAcell 150 incubator from Heraeus. Live 
HeLa cells were monitored using an x20 objective (Leica fluorescence microscope) 
under bright light and 488 nm (fluorescein) and 254 nm (Hoechst 33342) excitation, 
respectively. Fluorescence microscopy was performed on a Leica SP5 Confocal and 
Zeiss 510 Meta software was used for digital acquisition. 
Carboxylated cyanine 5 (Cy5) dye and 1-(9H-fluoren-9-yl)-3,12-dioxo-2-oxa-7,8-
dithia-4,11-diazapentadecan-15-oic acid (Fmoc-AED-Suc-OH) were from N. 
Nourozi and S.V. Chankeshwara, respectively. 
 
6.2 Functional molecules 
6.2.1 para-Vinylbenzylamine hydrochloride  
 
6 
PARA-VINYLBENZYLPHTHALIMIDE. para-Vinylbenzylphthalimide was prepared 
following a procedure of Delair.
52
  para-Vinylbenzylchloride (15.3 g, 100 mmol) and 
potassium phthalimide (18.5 g, 100 mmol, 1 equiv.) were added to DMF (50 mL) 
and stirred to give an orange suspension. The reaction mixture was stirred for 17 h. 
The solution was added to 1.7 M NaOH (1000 mL) and the precipitate was collected 
via filteration under vacuum. The residue was dissolved in EtOAc (100 mL) to give a 
cloudy white solution. The solvent was removed under reduced pressure and the 




product was purified by recrystallisation from MeOH (2 ×) to give para-
vinylbenzylphthalimide as a white solid (17.0 g, 64.6 mmol, 65%). 
1
H  NMR (250 
MHz, CDCl3) δ 7.79 (m, 4 H), 7.38 (m, 4 H), 6.67 (dd, J = 17.5 Hz, J = 10.9 Hz, 1 
H), 5.71 (d, J = 17.5, 1 H), 5.22 (d, J = 10.9, 1 H), 4.83 (s, 2 H). 
13
C NMR (62.5 
MHz, CDCl3) δ 168.3, 137.5, 136.6, 136.2, 134.3, 132.4, 129.2, 126.8, 123.7, 114.5, 
41.7. MS (ESI
+






PARA-VINYLBENZYLAMINE. para-Vinylbenzylamine was prepared following a 
procedure of Delair.
52
 para-Vinylbenzylphthalimide 6 (7.3 g, 27 mmol) was 
dissolved in nitrogen-flushed ethanol (75 mL) and heated under reflux until 
dissolution of the starting material. Hydrazine hydrate (2.6 g, 53 mmol, 1.9 equiv.) 
was added and the reaction mixture was stirred for 3 h. The solution was filtered and 
washed twice with EtOH (10 mL). The filtrate was concentrated in vacuo to give a 
white solid, which was treated with 1.5 M KOH (200 mL) and extracted with Et2O (3 
 150 mL). The combined organic phases were washed with 2% K2CO3 (150 mL), 
dried over MgSO4, and concentrated under reduced pressure to give the product as a 
white solid (2.3 g, 17.0 mmol, 64%). 
1
H NMR (250 MHz, CDCl3): δ 7.32 (m, 4 H), 
6.71 (dd, J = 17.6 Hz, J = 10.9 Hz, 1 H), 5.73 (d, J = 17.6, 1 H), 5.22 (d, J = 10.9, 1 
H), 3.84 (s, 2 H), 1.61 (s, 2 H). 
13
C NMR (62.5 MHz, CDCl3): δ 140.3, 138.7, 137.8, 




129.8, 128.2, 114.7, 45.2. MS (ESI
+
, MeOH : H2O) m/z 134.0 [M + H]
+
 (C9H11N); 






PARA-VINYLBENZYLAMINE HYDROCHLORIDE (VBAH). para-Vinylbenzylamine 
hydrochloride was prepared following a procedure of Delair.
52
 para-
Vinylbenzylamine (0.8 g, 6.3 mmol) was dissolved in MeOH (30 mL) and cooled to 
0 °C before 6 M aqueous HCl (9 mmol) in iso-propanol (1.5 mL) was slowly added 
over 1.5 h. Et2O (150 mL), was added slowly and the precipitate was recovered by 
filtration to give a white solid which was dried in vacuo to give VBAH (0.5 g, 2.8 
mmol, 45 %).  
1
H NMR (250 MHz, CD3OD): δ 7.44 (m, 4 H), 6.74 (dd, J = 17.7 Hz, 
J = 11.1 Hz, 1 H), 5.82 (d, J = 17.7, 1 H), 5.27 (d, J = 11.1, 1 H), 4.07 (s, 2 H). 
13
C 
NMR (62.5 MHz, CD3OD): δ 140.8, 138.2, 134.6, 131.1, 128.7, 116.2, 44.9. MS 
(ESI
+
, MeOH : H2O) m/z 134.0 [M – Cl]
+













6.2.2 Fmoc-4,7,10-trioxa-1,13-tridecaneediamine succinamic acid  
 
14 
FmocHN-PEG3-OH was prepared following a procedure of Zhao.
87
 A solution of 
succinic anhydride (1.0 g, 10 mmol, 1 equiv.) in MeCN (25 mL) was added drop 
wise, over 1 h, to 4,7,10-trioxa-1,13-tridecanediamine (2.2 g, 10 mmol) in MeCN (50 
mL) and stirred for a further 3 h until formation of a liquid and gel phase. The liquid 
phase was decanted and discarded. The gel phase was redissolved in MeCN : water  
(1 : 1, 50 mL) and the solution was cooled to 0 °C prior to the drop wise addition of 
Fmoc-O-succinimide (4.4 g, 13 mmol, 1.3 equiv.) in MeCN (25 mL), with the 
solution kept at approximately ‘pH 8’ by the addition of DIPEA.  
After 12 h the solvents were removed in vacuo and the residue dissolved in 5% 
aqueous NaHCO3 (100 mL) which was washed with EtOAc (3  50 mL). The 
aqueous phase was acidified to pH 2 with aqueous 1 M HCl, extracted with EtOAc 
(3  50 mL) and the organic phases were combined, washed with brine (50 mL) and 
dried over MgSO4 and concentrated in vacuo to give FmocHN-PEG3-COOH as a 
yellow oil (2.4 g, 4.4 mmol, 44%). 
13
C NMR (62.5 MHz, CDCl3): δ 175.3, 172.5, 
156.6, 143.9, 141.2, 127.5, 126.9, 124.9, 119.8, 70.2, 69.8, 69.1, 66.3, 47.1, 38.7, 
38.1, 30.7, 29.9, 29.2, 28.4. MS (ESI
+





; m/z 565.1 [M + Na]
+
.     
 




6.2.3 Fluorescein-based monomers§ 




FLUOROMETHANESULFONATE. A mixture of fluorescein (1.1 g, 3.2 mmol), N-
phenyl-bis(trifluoromethanesulfonimide) (1.3 g, 3.6 mmol) and potassium carbonate 
(0.65 g, 4.8 mmol) were stirred in DMF (10 mL) and microwave-irradiated at 80 C 
for 30 min. The reaction mixture was evaporated to dryness and the crude residue 
was partitioned between EtOAc (150 mL) and 1 M HCl (50 mL). The aqueous layer 
was extracted with EtOAc (2  50 mL), and the combined organic layers dried 
(MgSO4) and concentrated in vacuo. Purification of the residue via flash 
chromatography on silica gel (4 : 1 hexane : EtOAc) afforded the title product as an 
off-white solid (0.82 g,  1. 8 mmol, 56%).  
1
H NMR (500 MHz, DMSO-d6): δ 10.29 
(brs, 1H),  8.05 (d, J = 7.6 Hz, 1H),  7.83 (t, J = 7.5 Hz, 1H),  7.77 (t, J = 7.5 Hz, 
1H),  7.71 (d, J = 2.6 Hz, 1H),  7.38 (d, J = 7.6 Hz, 1H),  7.25 (dd, J = 2.6 Hz, J = 
8.8 Hz, 1H),  7.03 (d, J = 8.8 Hz, 1H),  6.76 (d, J = 2.6 Hz, 1H),  6.64 (d, J = 2.6 Hz, 
2H) ppm. 
13
C NMR (125 MHz, DMSO-d6): δ 168.9, 160.3, 152.6, 151.9, 151.7, 
150.1, 136.4, 131.0, 129.7, 126.1, 125.4, 124.6, 120.4, 117.7, 113.9, 111.2, 109.3, 
102.8, 81.8 ppm. MS (ESI) m/z 465.5 [M + H]
 +
. 
                                                          
§
 Fluorescein derivatives were jointly synthesised with Dr S. V. Chankeshwara. 







3-ONE (XANTHINE-STYRYL). A mixture of compound 31 (0.26 g, 0.5 mmol), 4-
vinylphenylboronic acid (90 mg, 0.6 mmol), palladium acetate (4.5 mg, 0.02 mmol) 
and triphenylphosphine (21 mg, 0.08 mmol) was stirred in dioxane (4.5 mL). 
Potassium carbonate (0.14 g, 1 mmol) in water (0.5 mL) was added and the resulting 
mixture was microwave irradiated at 120 C for 30 min. The reaction mixture was 
partitioned between EtOAc (40 mL) and 1 M HCl (10 mL), the aqueous layer was 
extracted with EtOAc (2  25 mL) and the combined organic phases dried (MgSO4) 
and filtered through celite. The filtrate was further treated with SiliaMetS® Thiol 
resin (2.5 g, 2 equiv, loading 1.41 mmol/g) overnight filtered and the organic layer 
concentrated in vacuo. Purification of the residue via flash chromatography on silica 
gel (4 : 1 Hexane : EtOAc) afforded the title compound as an orange solid (0.17 g, 
0.41 mmol, 82%). 
1
H NMR (500 MHz, CDCl3): δ 8.08 (d, J = 7.5 Hz, 1H),  7.68-
6.72 (m, 3H), 7.60 (d, J = 8.3 Hz, 1H), 7.52-7.54 (m, 3H), 7.30 (d, J = 7.2 Hz, 1H), 
7.23 (d, J = 7.5 Hz, 1H), 6.88 (d, J = 8.3 Hz, 1H), 6.81 (d, J = 2.5 Hz, 1H), 6.77 (dd, 
J = 10.9 Hz, J = 17.6 Hz, 1H), 6.71 (d, J = 8.6 Hz, 1H), 6.58 (dd, J = 2.5 Hz, J = 8.6 
Hz, 1H), 5.84 (d, J = 17.6 Hz, 1H),  5.39 (s, 1H) 5.33 (d, J = 10.9 Hz, 1H) ppm. 
13
C 
NMR (125 MHz, CDCl3): δ 169.7,  157.6, 153.3, 152.5, 151.6, 143.3, 138.9, 137.5, 




136.2, 135.2, 135.1, 129.8, 129.5, 128.5, 128.1, 127.3, 126.8, 126.6, 125.2, 123.9, 









YL)BENZOATE. A mixture of fluorescein (1.0 g, 3.0 mmol), 4-vinylbenzyl chloride 
(1.1 g, 7.0 mmol) and potassium carbonate (0.56 g, 4.0 mmol) was stirred in DMF 
(10 mL) at 60 C for 12 h. The reaction mixture was evaporated to dryness, the crude 
residue was added to water to precipitate the product. The precipitate was collected 
by filtration and dried under vacuum at 40 °C. The crude residue was purified by 
triturating with EtOAc and hexane to afford the title product as a yellow solid (1.51 
g, 2.7 mmol, 90%). 
1
H NMR (500 MHz, CDCl3): δ 8.30 (dd, J = 1.3 Hz, J = 7.8 Hz, 
1H)  7.73 (t, J = 7.5 Hz, 1H)  7.69 (t, J = 7.8 Hz, 1H)  7.49 (d, J = 8.2 Hz, 2H)  7.43 
(d, J = 8.2 Hz, 2H)  7.27 (d, J = 7.5 Hz, 1H)  7.20 (d, J = 8.2 Hz, 1H)  6.80-6.86 (m, 
4H)  6.80 (d, J = 2.4 Hz, 1H)  6.75-6.79 (m, 2H)  6.68-6.71 (m, 2H)  6.54 (dd, J = 
1.9 Hz, J = 9.7 Hz, 1H)  6.33 (d, J = 1.9 Hz, 1H)  5.80 (dd, J = 6.9 Hz, J = 17.6 Hz, 
2H)  5.30-5.34 (m, 2H)  5.15 (s, 2H)  4.93 (d, J = 2.1 Hz, 2H)  ppm. 
13
C NMR (125 
MHz, CDCl3): δ 185.6, 171.2, 165.4, 162.8, 158.6, 136.3, 136.2, 135.0, 135.6, 133.6, 




132.7, 131.5, 130.4, 130.2, 130.0, 128.9, 127.7, 126.6, 126.4, 114.7, 114.6, 113.8, 








XANTHEN]-3-ONE (O-XANTHINE STYRYL). Compound 33 (1.31 g, 2.0 mmol) was 
dissolved in THF (5 mL) and lithium hydroxide (0.14 g, 6.0 mmol) dissolved in 
water (5 mL) was added and the resultant mixture was heated at 50 °C for 6 h. After 
completion of reaction (tlc), the reaction mixture was evaporated to dryness. The 
crude residue obtained was added to water and acidified to pH ~3 by the addition of 
concentrated HCl (3 mL) to precipitate the product from the aqueous layer. The 
precipitate was collected by filtration, washed with water (3  10 mL) and dried 
overnight under vacuum at 40 °C to afford the title product as a yellow solid (0.72 g, 
1.6 mmol, 80%). 
1
H NMR (500 MHz, CDCl3): δ 8.05 (d, J = 7.6Hz, 1H), 7.69 (t, J = 
7.5 Hz, 1H), 7.64 (t, J = 7.5 Hz, 1H), 7.46 (d, J = 8.2 Hz, 2H), 7.40 (d, J = 8.2 Hz, 
2H), 7.19 (d, J = 7.6 Hz, 1H), 6.84 (dd, J = 10.4 Hz, J = 17.0 Hz, 1H), 5.29 (d, 1H), 
6.70-6.79 (m, 4H), 6.62 (d, J = 8.6 Hz, 1H), 6.52 (d, J = 8.6 Hz, 1H), 5.93 (br s, 1H), 
5.79 (d, J = 17.0 Hz, 1H), 5.29 (d, J = 10.4 Hz, 1H), 5.10 (s, 2H) ppm.
 13
C NMR 
(125 MHz, CDCl3): δ 169.9, 160.5, 157.8, 153.2, 152.5, 152.4, 137.6, 136.4, 135.8, 
135.2, 129.8, 129.4, 129.2, 127.2, 126.8, 126.5, 125.1, 124.0, 114.3, 112.3, 111.3, 
111.2, 103.2, 101.9, 70.1 ppm. MS (ESI) m/z 448.9 [M + H]
 +
. 









The titled compound was prepared following the originally reported procedure.
226
 5-
Aminofluorescein (0.46 g, 1.32 mmol) was suspended in 12 N (4 mL) HCl and 3 g of 
ice was added. The mixture was cooled and stirred in an ice / water bath. Sodium 
nitrite (0.13 g, 1.9 mmol) in water (3 mL) was added dropwise over 2 min. The 
mixture was stirred for 30 min at 0 °C, then potassium iodide (2.9 g, 14.5 mmol) in 
water (4 mL) was added dropwise over 2 min with vigorous stirring at 0 °C. The 
cooling bath was removed and stirring was continued for a further 1 h. The reaction 
mixture was extracted with 25% iPrOH/CHCl3 (3  40 mL). The combined organic 
extracts were washed with saturated aqueous Na2S2O3 (40 mL), then dried over 
Na2SO4 and concentrated in vacuo. The resulting residue was adsorbed onto silica 
and purified by flash chromatography eluting with 10% MeOH/CH2Cl2 to afford a 
yellow solid  (0.25 g, 0.86 mmol, 65%) of 5-iodofluorescein. 
1
H NMR (500 MHz, 
DMSO-d6): δ 10.16 (brs, 2H),  8.31 (d, J = 1.5 Hz, 1H),  8.11 (dd, J = 1.5 Hz, J = 8.1 
Hz, 1H),  7.10 (d, J = 8.1 Hz, 1H),  6.68 (d, J = 2.4 Hz, 2H),  6.63 (d, J = 8.7 Hz, 
2H),  6.57 (d, J = 2.4 Hz, 1H),  6.55 (d, J = 2.4 Hz, 1H) ppm.
 13
C NMR (125 MHz, 
DMSO-d6): δ 167.6, 160.1, 152.3, 152.2, 144.4, 133.5, 129.7, 128.9, 126.6, 113.2, 











XANTHEN]-3-ONE (PHTHALIC-STYRYL). A mixture of compound 35 (0.23 g, 0.5 
mmol), 4-vinylphenylboronic acid (90 mg, 0.6 mmol), palladium acetate (4.5 mg, 
0.02 mmol) and triphenylphosphine (21 mg, 0.08 mmol) were stirred in dioxane (4.5 
mL). Potassium carbonate (0.14 g, 1 mmol) in water (0.5 mL) was added and the 
resulting mixture was microwave irradiated at 120 C for 30 min. The reaction 
mixture was partitioned between 25% iPrOH/CHCl3 (50 mL) and 1 M HCl (10 mL), 
the aqueous layer was extracted with 25% iPrOH/CHCl3 (2  25 mL) and the 
combined organic phases were dried over MgSO4 and filtered through celite. The 
filtrate was further treated with SiliaMetS® Thiol resin (2.5 g, 2 equiv., loading 1.41 
mmol/g) overnight filtered and the filtrate concentrated in vacuo. Purification of the 
residue via flash chromatography on silica gel (4 : 1, hexane : EtOAc) afforded the 
title compound as a yellow solid (0.15 g, 0.35 mmol, 70%). 
1
H NMR (500 MHz, 
DMSO-d6): δ 10.15 (brs, 2H),   8.23 (d, J = 1.2 Hz, 1H),   8.12 (dd, J = 1.7 Hz, J = 
8.0 Hz, 1H), 7.84 (d, J = 8.4 Hz, 2H),  7.64 (d, J = 8.4 Hz, 2H),  7.36 (d, J = 8.0 Hz, 
1H),  6.83 (dd, J = 11.5 Hz, J = 17.7 Hz, 1H,),   6.70 (d, J = 2.4 Hz, 2H),   6.67 (s, 
1H),   6.65 (m, 1H),   6.59 (d, J = 2.4 Hz, 1H),  6.57 (d, J = 2.4 Hz, 1H),  5.96 (d, J 
= 17.7 Hz, 1H),  5.35 (d, J = 11.5 Hz, 1H)  ppm.
 13
C NMR (125 MHz, DMSO-d6): δ 




169.0, 160.0, 152.3, 151.9, 142.1, 138.3, 137.6, 136.5, 134.5, 129.6, 127.8, 127.6, 







2-acetyldimedone was synthesised according to a procedure by Bycroft.
227
 DCC (7.4 
g, 35.7 mmol, 1 eq.) was added to a solution of dimedone (5.0 g, 35.7 mmol) and 
DMAP (0.4 g, 3.6 mmol, 0.1 equiv.) in 75 mL DMF. Subsequently, acetic acid was 
added to the solution and the reaction mixture was stirred for 60 h. The solvent was 
removed under reduced pressure, the solid compound re-dissolved in EtOAc (50 mL) 
and the organic layer washed with 1 M HCl (50 mL). The organic layer was dried 
over Na2SO4 and the solvent evaporated under reduced pressure. The compound was 
purified via flash chromatography (SiO2, EtOAc : hexane, 2 : 1) to yield 3.7 g (20.0 
mmol, 56%) of the title compound as a yellow oil. 
1
H-NMR (200 MHz, CDCl3) δ 
2.65 (s, 3 H), 2.59 (s, 2 H), 2.41 (s, 2 H), 1.13 (s, 6 H). 
13
C-NMR (60 MHz, CDCl3) δ 














Fmoc-Lys(Dde)-OH was synthesised according to a procedure by Bycroft.
227
 
Trifluoroacetic acid (45 µL, 0.6 mmol, 0.1 eq.) was added to a suspension of Dde-
OH (2.14 g, 11.8 mmol, 2 equiv.) and Fmoc-Lys-OH (2.17 g, 5.9 mmol) in ethanol 
(60 mL) and refluxed at room temperature for 60 h. The reaction mixture was 
monitored by analytical tlc (95 : 5, EtOAc : hexane). The reaction mixture was 
concentrated under reduced pressure and the residue re-suspended in EtOAc (100 
mL), washed with 1 M aqueous KHSO4 (2 x 150 mL) and dried over MgSO4. The 
product was purified by flash chromatography (SiO2, DCM : MeOH, 8 : 1) to afford 
a white solid (1.6 g, 50%). 
1
H-NMR (200 MHz, CDCl3) δ 1.02 (s, 6H), 1.24-1.28 (m, 
2H), 1.46-1.61 (m, 2H), 1.67-1.80 (m, 2H), 2.17 (s, 3H), 2.53-2.55 (m, 4H), 3.42 (s, 
2H), 4.21 (t, 1H), 4.47 (dd, J = 7.1 Hz, J = 12.6 Hz, 1H), 5.66 (d,  J = 7.9 Hz, 2H), 
7.30 (ddt, J = 1.1 Hz, J = 2.2 Hz, J = 7.5 Hz, 2H), 7.39 (t, J = 7.4 Hz, 2H), 7.59 (t, J 
= 7.7 Hz, 2H), 7.75 (d, J = 7.6 Hz, 2H), 13.32 (s, 1H). 
13
C-NMR (60 MHz, CDCl3) δ 
18.5, 23.0, 28.6, 30.5, 43.7, 52.8, 67.4, 108.1, 120.4, 125.5, 127.5, 128.1, 141.6, 
144.1, 144.3, 156.8, 174.4, 175.7, 198.7. MS (ESI) m/z 533.2 [M + H]
+









6.2.5 Fluorescein quencher probe 
 
The fluorescein-based quencher probes were synthesised by Fmoc-solid phase 
chemistry on PS Rink-amide resin (loading: 1.23 mmol/g, size: 30 – 40 µm, cross-
linking: 1% DVB). Amide bond couplings were carried out under identical 
conditions until full length of the molecule had been prepared (Table 6.1 and 6.2). 
Following coupling of Lysine(Dde), the ε-amino group was deprotected and 
subsequently coupled with fluorescein (Lys-5) and methyl red (Lys-8), respectively, 
prior Fmoc-deprotection of the α-amino group.. 
 Coupling procedure. The Fmoc-amino acid residue (3 equiv.) was shaken with 
oxyma (3 equiv.) and DIC (3 equiv.) in DMF (0.5 mL) for 10 min prior to addition to 
the resin in (pre-swollen in) DMF (0.5 mL) and shaking for 1.5 h. The resin was 
washed with DMF (5 ×1 mL) and MeOH (5 × 1 mL).
 
 Fmoc-deprotection was 




carried out with 20% piperidine in DMF (2 × 1 mL) for 10 min, followed by washing 
with DMF (5 × 1 mL) and MeOH (5 × 1 mL).
  
DDE-DEPROTECTION. The resin was treated with DMF : cleaving solution (1 : 5) 
for 1 × 1 mL (2 min) and 5 × 1 mL (10 min) and shaken, followed by washing with 
DMF (5 × 1 mL) and MeOH (5 × 1 mL). The cleaving solution consisted of 
hydroxylamine hydrochloride (1.25 g, 1.8 mmol) and imidazole (0.92 g, 1.35 mmol) 
in N-methylpyrrolidone (5 mL).
162
 
PROBE CLEAVAGE. Resin was suspended in a cleavage solution (1 mL) consisting 
of 95% TFA, 2.5% water and 2.5% triisopropylsilane and shaken for 3 h. The resin 
was removed by filtration, the cleavage solution was evaporated by a flow of air and 
the peptide re-dissolved in water and lyophilised.  
57: (MALDI-ToF) found: m/z 1863.6 [M + H]
+
; calcd. 1862.8; HPLC (λ = 495 nm 
eluent A: water and formic acid (0.1 %); eluent B: acetonitrile, formic acid (0.1%) (A 
= 95%  5 min, 95% to 5% over 20 min) Retention time: 14.5 min (purity: 99%).  
58: (MALDI-ToF) found: m/z 1855.9 [M + Na]
+
; calcd. 1854.8; HPLC (λ = 495 nm 
eluent A: water and formic acid (0.1 %); eluent B: acetonitrile, formic acid (0.1%) (A 












Table 6.1. Reaction conditions for the synthesis of disulphide-linked probe 57. 
Residue n / mmol equiv. m / mg V / µL 
Aminomethyl 
PS resin 
0.1 1 80 - 
Rink amide linker 0.3 3 162 - 
Oxyma 0.3 3 43 - 
DIC 0.3 3 - 47 
Fmoc-Asp(O
t
Bu)-OH 0.3 3 123 - 
Fmoc-Gly-OH 0.3 3 89 - 
Fmoc-Lys(Dde)-OH 0.3 3 160 - 
Fmoc-Ahx-OH 0.3 3 106 - 
Fmoc-ADE-OH 0.3 3 163 - 
p-Iodobenzoic acid 0.3 3 74 - 
Methyl red 0.3 3 79 - 














Table 6.2. Reaction conditions for the synthesis of Ahx-linked probe 58. 
Residue n / mmol equiv. m / mg V / µL 
Aminomethyl 
PS resin 
0.1 1 80 - 
Rink amide linker 0.3 3 162 - 
Oxyma 0.3 3 43 - 
DIC 0.3 3 - 47 
Fmoc-Asp(O
t
Bu)-OH 0.3 3 123 - 
Fmoc-Gly-OH 0.3 3 89 - 
Fmoc-Lys(Dde)-OH 0.3 3 160 - 
Fmoc-Ahx-OH 0.3 3 106 - 
p-Iodobenzoic acid 0.3 3 74 - 
Methyl red 0.3 3 79 - 















6.3 Particle synthesis  
6.3.1 Aminomethyl-functionalised polystyrene-based particles 
 
4 
Aminomethyl-functionalised polystyrene-based particles were prepared following 
a procedure by Sanchez-Martin.
41
 Styrene (122 µL, 1 mmol, freshly washed with 4  
25% NaOH and 4  brine), divinylbenzene (DVB) (3.1 µL, 22 µmol, 2 mol% with 
regards to styrene, freshly washed with 4  25% NaOH and 4  brine), VBAH 4 (5.9 
mg, 35 µmol, 3 mol%), 2,2-azobis (2-methylpropionamidine) dihydrochloride (V-50) 
(1.6 mg, 6 µmol) and MgSO4 (0.4 mg, 3 µmol) were added to nitrogen-purged water 
(2 mL) and stirred for 15 min under a nitrogen atmosphere. The reaction mixture was 
stirred at 80 ºC for 15 h. The particles were collected by centrifugation (15 min at 
30,000 g) and washed with DMF (3  2 mL), MeOH (3  2 mL) and water (3  2 
mL). The particles were stored in water at a solid content of 2%.  
 
Table 6.3. Properties of aminomethyl-functionalised polystyrene-based particles. 
Particle Size / nm  PDI Amine-loading  Yield  
4a 232 0.027 135 µmol/g 43% 
4b 240 0.037 70 µmol/g 27% 
4c 224 0.014 78 µmol/g 23% 
4d 229 0.060 82 µmol/g 34% 
 




6.3.2 Fluorescent aminomethyl-functionalised polystyrene-based 
particles  
 
Styrene (122 µL, 1 mmol, freshly washed with 4  25% NaOH and 4  brine), 
divinylbenzene (DVB) (3.1 µL, 22 µmol, 2 mol% with regards to styrene, freshly 
washed with 4  25% NaOH and 4  brine), VBAH 4 (5.9 mg, 35 µmol, 3 mol%) 
fluorescein derivatives (35 µmol, 3 mol%, Table 6.4), V-50 (1.6 mg, 6 µmol) and 
MgSO4 (0.4 mg, 3 µmol) were added to nitrogen-purged water (2 mL) and stirred for 
15 min under a nitrogen atmosphere. The reaction mixture was stirred at 80 ºC for 15 
h. The particles were collected by centrifugation (15 min at 30,000 g) and washed 
with DMF (3  2 mL), MeOH (3  2 mL) and water (3  2 mL). The particles were 












Table 6.4. Fluorescein monomer contents and particle properties. 




38 32 14.6 35 (3 mol%) 189 (0.099) 121 
39 34 15.7 35 (3 mol%) 217 (0.043) 114 
40a 37 15.3 35 (3 mol%) 187 (0.041) 105 
40b 37 15.3 35 (3 mol%) 248 (0.093) 119 
 
6.3.3 Boronic acid and aminomethyl-functionalised particles 
 
45 
Styrene (122 µL, 1 mmol, freshly washed with 4  25% NaOH and 4  brine), p-
divinylbenzene (3.1 µL, 22 µmol, 2 mol% with regards to styrene, freshly washed 
with 4  25% NaOH and 4  brine), VBAH 1 (5.9 mg, 35 µmol, 3 mol%), p-
vinylbenzylboronic acid (see Table 6.5), V-50 (1.6 mg, 6 µmol) and MgSO4 (0.4 mg, 
3 µmol) were added to nitrogen-purged water (2 mL) and stirred for 15 min under a 
nitrogen atmosphere. The reaction mixture was stirred at 80 ºC for 15 h. The particles 
were collected by centrifugation (15 min at 30,000 g) and washed with DMF (3  2 
mL), MeOH (3  2 mL) and water (3  2 mL). The particles were stored in water at a 








Table 6.5. para-Vinylbenzylboronic acid contents and particle properties. 






45 5.2 35 (3 mol%) 240 (0.071) 129  62 
46 10.4 70 (6 mol%) 260 (0.190) 163 116 
47 15.5 105 (9 mol%) 211 (0.313) 76 204 
 
6.3.5 Characterisation of particles 
SOLID CONTENT. Solid contents of particles were determined by drying the 
particle suspension (100 µL) under vacuum (< 20 bar) at 40 °C overnight and 
weighing. The solid content was calculated from the dry mass using equation 6.1.   
 
Equation 6.1. Determination of the solid content. 
      [ ]   
 
 
       
 
sc Solid content in %  
m Mass in mg 
V  Volume in µL 
 
AMINE LOADING – QUALITATIVE AND QUANTITATIVE KAISER TEST. Quantitative 
and qualitative contents of free aminomethyl groups were determined via the Kaiser 
test as reported previously.
54,55
 The analytical sample was prepared by washing a 
dispersion of particles (3 mg) with MeOH (2  500 µL) and removing the 
supernatant. The Kaiser test was carried out by the addition of Kaiser test solutions 




(90 µL solution A and 30 µL solution B) to the particles followed by heating to 110 
ºC for 3 min. Kaiser test solutions: solution A (1.3 mg KCN in water (2 mL), phenol 
: EtOH (8 : 2; 50 mL), freshly distilled pyridine (100 mL)) and solution B (2.5 g 
ninhydrin in EtOH (50 mL)).  
Afterwards 60% aqueous EtOH (0.5 mL) was added and the reaction mixture was 
centrifuged. The particles were twice washed with 60% EtOH and the absorbance of 
the combined supernatant was measured at 570 nm. The amine content was 
determined from the Beer-Lambert law (Equation 6.2). 
 
Equation 6.2. Amine-loading determination via the Beer-Lambert law. 
  [
   l
 
    
A          
        l
 
          Loading 
A Absorbance 
V  Volume in mL 
ε   Extinction coefficient (ε570, Ruheman’s Purple = 15,000 L · (cm · mol)
-1
) 
m  Mass in mg 
l   Path length in cm 
 
ELLMAN’S TEST. Free thiol groups were detected using the Ellman test.
57
 A 
particle suspension (50 µL, 1 mg) was added to 5,5´-dithiobis-(2-nitrobenzoic acid 
(DTNB) (50 µL) solution (50 mM sodium acetate and 2 mM DTNB in water), 100 
µL Tris-buffer (1 M, pH 8) and 800 µL water and incubated for 5 min at room 
temperature. Formation of a yellow colour indicated the presence of free thiols.   




FMOC-QUANTIFICATION.  Fmoc-content was determined as reported 
previously.
228
 The sample was prepared by washing a dispersion of particles (3 mg) 
in DMF (3 × 500 µL). Afterwards, 20% piperidine in DMF (500 µL) were added and 
the mixture shaken for 20 min and the supernatant removed (2 ×). The absorbance of 
the combined supernatant was determined at 301 nm in a quartz cuvette and the 
Fmoc content calculated by the Beer-Lambert law (Equation 6.2, ε301, Fmoc = 4,800 L · 
(cm · mol)
-1).   
PARTICLE SIZE – DYNAMIC LIGHT SCATTERING. The hydrodynamic diameter was 
determined with a Malvern Zetasizer Nano-ZS. A suspension of particles 1 µL was 
diluted in 10% PBS (pH = 7.4, 8 g/L NaCl, 0.2 g/L KCl, 1.15 g/L Na2HPO4, 0.2 g/L 
KH2PO4) in water (1 mL), vortexed and transferred into a 4 mL polystyrene cuvette 
(FB55143, Fisher Scientific). This solution was measured and resulted in a light 
scattering intensity which was converted into the hydrodynamic diameter. The data 
were collected and analysed with the Dispersion Technology Software 4.20 
(Malvern) giving histograms for the particles size as a number distribution.  
PARTICLE SIZE AND SHAPE – SCANNING ELECTRON MICROSCOPY. A solution of 
10 µL particle suspension was dried onto carbon-coated stubs under vacuum (40   C, 
12 h) and gold coated by sputtering (approximately a 20 nm layer) before analysis on 
a Phillips XL30CP Scanning Electron Microscope.   
SURFACE AREA MEASUREMENT – BET. Surface areas of particles 4a were 
determined on a Micromeritics Gemini 2370. An aqueous dispersion containing 150 
mg of sample was dried under vacuum overnight in a glass vial. The dry sample was 
attached to the BET-device and a fully automatic program was started. Briefly, the 
sample was cooled in liquid nitrogen and evacuated until generation of a stable 




vacuum, followed by pressurisation with different nitrogen pressures and 
measurement of the resulting nitrogen pressure. The measurement was repeated 
thrice to give an average value. The pressure data were internally transformed by use 
of the Brunauer-Emmett-Teller equation to give a surface area of (29.6 ± 0.5) m
2
/g.        
ZETA POTENTIAL – LASER DOPPLER VELOCIMETRY. The zeta potential was 
determined with the Zetasizer Nano-ZS equipped with an MPT-2 autotitrator from 
Malvern Instruments. A suspension of 1 µL particles was diluted in 10% PBS (pH = 
7.4, 8 g/L NaCl, 0.2 g/L KCl,  1.15 g/L Na2HPO4, 0.2 g/L KH2PO4) in water (1 mL), 
vortexed and transferred into a 1 mL clear zeta potential cuvette (DTS1060, 
Malvern). The solution was measured and resulted in a electrophoretic mobility 
which was converted into the hydrodynamic diameter. Titration experiments were 
carried out using the fully automated MPT-2 autotitrator. Particles were suspended in 
pure water and titrated against NaOH (0.1 M). Zeta potential measurements were 
determined at ΔpH 0.5 intervals. The data were collected and analysed with the 
Dispersion Technology Software 4.20 (Malvern) giving zeta potential distributions.  
FLUORESCENT MEASUREMENT – FLOW CYTOMETRIC ANALYSIS. A suspension of 
particles (1 µL, 20 µg, solid content 20 mg/mL) was diluted in 350 µL of water, 
vortexed and measured (Table 6.6, Fluorescein: λex = 488 nm, λem = 515-545 nm 










Table 6.6. Particle fluorescence measurement. 
Fluorophore Particle Intensity Particle Intensity 
Fluorescein 4c 139 41 9220 
 38 8210 45 4 
 39 24460 51 1923 
 40a 51010 52 248 
 40b 72000 53 229 
Cy5 45 6 59 12100 
 
METAL AND METALLOID CONTENT – ICP-OES. Boron and palladium content of 
the particle suspensions were determined as reported previously.
155
 A suspension of 
the particles (3 mL, 1 mg/mL) in 0.5 wt% SDS in water was prepared and analysed 
by ICP-OES using a Perkin Elmer Optima 5300 DV, employing an RF forward 
power of 1400 W, with argon gas flows of 15, 0.2 and 0.75 L/min for plasma, 
auxiliary, and nebuliser flows, respectively (Table 6.7). Using a peristaltic pump, 
sample solutions were taken up into a Gem Tip cross-Flow nebuliser and Scotts 
spray chamber at a rate of 1.5 mL/min. The instrument was operated in axial mode 
for B and Pd. A range of calibration standards were prepared using single element 
1000 mg l
-1
 stock solutions (boron: Fisher Scientific UK LTD; palladium: Merck 
certipur), diluted with 0.5 wt%/v SDS dissolved in deionised water (18Ω, Elga USF). 
A Merck multi element standard (ICP Multi element standard solution VI 
CertiPUR®) was employed as a reference standard for boron. The selected 
wavelengths for each element and were analysed in fully quantitative mode (three 
points per unit wavelength). Five replicate runs per sample were employed to ensure 




that the suspension remained stable throughout each analysis. In addition each 
sample was sonicated for 3 minutes prior to analysis. The boron concentration was 
determined using the emission line at 249.677 nm while the concentration of 
palladium was determined at 248.892 nm. Standards:  0, 0.1, 1, 2, 10, and 20 mg/l 
were prepared for each element.  The majority of the samples fell below 10 mg/l, and 
were therefore re-calculated against a calibration up to 10 mg/l. With all of the 
calibration lines the correlation coefficients for the linear regression were 0.9997 or 
better.  
 
Table 6.7. Boron and palladium measurement of particles. 
Fluorophore Particle c / µmol/g Particle c / µmol/g 
Boron 4d (2 ± 1) 52 (61 ± 1) 
 45 (62 ± 1) 53 (60 ± 1) 
 46 (116 ± 2) 60 (48 ± 2) 
 47 (204 ± 1) 61 (37 ± 2) 
 51 (36 ± 1)   
Palladium 51 < 0.01   
 
 
6.4 Particle modification 
6.4.1 General amide bond formation procedure 
Ethyl-2-cyano-2-(hydroxyimino) acetate (oxyma)/diisopropylcarbodiimide (DIC) 
couplings were carried out.
86
 Particle dispersion (75 mg, 1 mL, 10 μmol, 1 equiv.) 
were washed with DMF (3 × 1 mL) with centrifugation (30,000 g) and re-dispersed 




in DMF (500 µL). Oxyma (7 mg, 50 µmol, 5 equiv.) and DIC (8 µL, 50 µmol, 5 
equiv.) were added to the acid (Table 6.8) in DMF (200 µL) and shaken for 10 min 
prior addition to the particle dispersion. The reaction mixture was heated to 60 °C 
using microwave irradiation for 20 min. Afterwards, the particles were washed in 
DMF (3 × 1 mL), MeOH (2 × 1 mL) and water (2 × 1 mL) and successful 
conjugation verified with the Kaiser test.  
 
Table 6.8. Oxyma/DIC mediated conjugation onto polymeric particles. 
Particle Acid nAcid m 
10, 72 p-Sulfobenzoic acid 50 µmol 9 mg 
11 Hydroxycaproic acid 50 µmol 7 mg 
12, 68 Fmoc-Glu(OtBu)-OH 50 µmol 22 mg 
15, 42, 70, 73, 74 Fmoc-HN-PEG3-OH 50 µmol 27 mg 
41 5(6)-Carboxyfluorescein 50 µmol 19 mg 
60 Cyanine 5 (3 equiv.) 30 µmol 14 mg 
71 – 73  Fmoc-Aminohexanoic acid 50 µmol 18 mg 
63, 66 p-Hydroxybenzoic acid 50 µmol 7 mg 
 
6.4.2 Guanidinium-conjugated particles 
A solution of N´,N-bis-(tert-butoxycarbonyl)-S-methylurea (15 mg, 50 μmol, 5 
equiv.) in DMF (0.2 mL) and TEA (4 μL, 50 μmol, 5 equiv.) was added to 
prewashed (DMF, 3 × 1 mL) particles 4a (1 mL, 75 mg, 10 μmol, 1 equiv) in DMF 
(2 mL) and heated  to 60 °C under microwave irradiation for 30 min. The particles 
(8, 69) were washed with DMF (3 × 1 mL) with centrifugation (30,000 g for 15 min). 




6.4.3 Carboxylated particles 
A solution of DIC (8 μL, 50 μmol, 5 equiv.) in DMF (100 μL) was added to adipic 
acid (7 mg, 50 μmol, 5 equiv.) or 3,3-dithiopropionic acid (11 mg, 50 μmol, 5 equiv) 
in DMF (1 mL), and the mixture was shaken for 10 min and subsequently added to 
prewashed (DMF, 3 × 1 mL) particles 4a (9, 18, 19) or 40b (65) (75 mg, 10 μmol, 1 
equiv.) and N,N´-diisopropylethylamine (DIPEA) (2 μL, 10 μmol, 1 equiv.) in DMF 
(2 mL). The reaction mixture was heated to 60 °C using microwave irradiation for 20 
min. Finally, particles were washed with DMF (3 × 2 mL) with centrifugation 
(30,000 g for 15 min). 
 
6.4.4 NTA-conjugation 
Attachment of 5-amino-3-(bis-(carboxymethyl)amino)pentanoic acid (NTA) was 
carried out by preactivation with oxyma (0.3 mg, 2 μmol, 1 equiv.) and DIC (0.3 μL, 
2 μmol, 1 equiv) in DMF (0.2 mL) of acid-functionalised particles (15 mg, 2 μmol, 1 
equiv.) followed by addition of NTA (2 mg, 6 μmol, 3 equiv.) and heating to 60 °C 
under microwave irradiation for 20 min. Afterward, the particles 21 were washed, 
with centrifugation (30,000 g for 15 min) with DMF (3 × 2 mL). 
 
6.4.5 N-Acetylated particles 
Particles 4a (16) or 40c (67) (1 mL, 75 mg, 10 μmol, 1 equiv.) were washed with 
DMF (3 × 2 mL), and the supernatant was removed. A solution of acetic anhydride, 
pyridine, and DMF (2:3:15 (v/v/v), 1 mL) was added and the reaction mixture shaken 
for 10 min. The particles were centrifuged, the supernatant was removed, and the N-




acetylation reaction was repeated. The reaction mixture was removed and washed 
with DMF (3 × 2 mL) with centrifugation (30,000 g for 15 min). 
 
6.4.5 Disulphide-reduction  
TCEP-MEDIATED DISULPHIDE BOND CLEAVAGE. Particles 19 (7.5 mg, 1 μmol), 
previously coupled to 3,3´-dithiopropionic acid, were washed with PBS (3 × 2 mL, 
pH 7.4) and suspended in a solution of 50 mM tris(2-carboxyethyl)phosphine 
(TCEP) in PBS (pH 7.4, 1 mL). The reaction mixture was shaken for 3 h at 30 °C. 
Finally, the particles were washed with PBS (3 × 1 mL, pH 7.4) with centrifugation 
(30,000 g for 15 min).  
DTT-MEDIATED DISULPHIDE BOND CLEAVAGE. Particles (61, 62) (1 mg) were 
suspended in a solution of 10 mM dithiothreitol (DTT) in PBS (100 µL, pH 7.4) and 
shaken at 37 °C for 1 h. Afterwards, the particle suspension (61a, 62a) was 
centrifuged and the fluorescence of the supernatant measured (in PBS at pH 7.4; λex 
= 488 nm; λem, max = 518 nm).  
 
6.4.8 Suzuki-Miyaura cross coupling 
 
48 
CATALYST (48) PREPARATION. A solution of the catalyst was prepared as reported 
previously.
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 2-Amino-4,6-dihydroxypyrimidine (13 mg, 10 mmol) was dissolved in 
NaOH (0.1 M, 2 mL) at 65 °C. Pd(OAc)2 (11 mg, 50 mmol) was added, the solution 




stirred at 65 °C for 30 min and 3 mL of water added to give a stock solution of 10 




5-IODOFLUORESCEIN CONJUGATION. Conjugation of 5-iodofluorescein 35 onto 
(HO)2B/H2N-particles 45 was carried out by Suzuki-Miyaura cross coupling. A stock 
solution of 5-iodofluorescein (25 mg, 55 µmol) in DMSO (550 µL) was prepared and 
reactions carried out as indicated in Table 6.9. Catalyst levels, as given in Table 6.9, 
were added to a suspension of (HO)2B/H2N-particles (10 mg, 0.11 µmol) in PBS 
(400 µL, pH 7.4) with sonication for 1 min. The reaction mixture was shaken at 
1,400 rpm at 37 °C for 15 h. Control reactions were carried out with fluorescein [52] 













Table 6.9. Suzuki-Miyaura cross coupling of 5-iodofluorescein 35. 
5-Iodofluorescein  5-Iodofluorescein Catalyst (5 %) 
6.25 equiv. 0.3 mg, 0.7 µmol 7 µL, 0.03 µmol 
12.5 equiv. 0.6 mg, 1.4 µmol 14 µL, 0.07 µmol 
25 equiv. 1.3 mg, 2.7 µmol 27 µL, 0.14 µmol 
50 equiv. 2.5 mg, 5.5 µmol 55 µL, 0.28 µmol 
75 equiv. 3.8 mg, 8.2 µmol 82 µL, 0.42 µmol 
100 equiv. 5.0 mg, 11 µmol 110 µL, 0.56 µmol 
 
 
Probe conjugation. Conjugation of fluorescein quencher probes (disulphide-
linked 57, Ahx-linked 58) were carried out by Suzuki-Miyaura cross coupling. A 
solution of the respective probe (13 mg, 7 µmol) in DMSO (50 µL) was prepared and 
added to a suspension of Cy5-labelled (HO)2B-particles 59 (13 mg, 0.14 µmol (-
B(OH)2)) in PBS (300 µL, pH 7.4) and sonicated for 1 min. The catalyst stock 
solution (5%, 0.35 µmol) was added and the reaction mixture shaken at 1,400 rpm at 




37 °C for 15 h followed by washing the particles with PBS (1  500 µL), DMF (3  
500 µL), MeOH (3  500 µL) and water (3  500 µL). The reaction was verified by 
ICP-OES measurement via relative boron concentration measurements with respect 
to the concentration prior to coupling (77% ± 1% (disulphide-linker) and 60% ± 1% 
(Ahx-linker)) and DTT-induced induced fluorescein release (see 6.4.5).  
 
6.4.9 Protecting group removal 
FMOC-DEPROTECTION. Particles were washed in DMF (3 × 2 mL) and the 
supernatant removed. A solution of 20% piperidine in DMF (2 mL) was added to the 
particles and the reaction mixture was shaken for 20 min. The particles were 
centrifuged (30,000 g for 15 min), the supernatant was removed, and the procedure 
repeated. The particles were washed in DMF (3 × 1 mL), MeOH (3 × 1 mL) and 
water (3 × 1 mL). 
tBUTYLESTER AND tBUTYLOXYCARBONYL CARBAMATE DEPROTECTION. 
Functionalised particles with 
t
Bu 12 and Boc 8 protecting groups on side chains of 
amino acids were washed in DMF (3 × 2 mL) and re-suspended in a solution of 20% 
TFA in DMF (2 mL). The reaction mixture was shaken for 4 h followed by 
centrifugation of the particles, removal of the supernatant, and washing with DMF (3 
× 2 mL) with centrifugation (30,000 g for 15 min). 
 
6.5 Protein adsorption 
6.5.1 Serum binding assay 
Polymeric particles (4a, 8 – 10, 12, 15, 16, 63 and (40b, 43b, 71 – 74) and metal 
oxide nanoparticles (NiO and Co3O4, Nanostructural and Amorphous Materials) 




from a aqueous solution in water (particle amount: surface area 29.6 mm
2
) were 
incubated with Dubelcco’s modified Eagle medium (DMEM) supplemented with 
10% fetal bovine serum (FBS), glutamine (4 mM) and antibiotics (penicillin and 
streptomycin, 100 units/mL) or in reduced-serum medium (Opti-minimal essential 
medium; Opti-MEM
TM
) and gently shaken (800 rpm) for 24 h. The samples were 
centrifuged to pellet the particles with protein attached to the surface and the 
supernatant was removed. The pellets were re-suspended and washed trice in sterile 
PBS to remove any non-binding proteins. The proteins were removed from the 
particles by re-suspension of the particles in SDS-sample buffer (0.5M Tris-HCl (pH 
8.8), SDS 4% (w/v), glycerol 20% (v/v), 2-mercaptoethanol 2% (v/v), and 
bromophenol blue 0.0025% in distilled/deionized water) and subsequent boiling of 
the sample for 5 min. The proteins were separated on a mini-PROTEAN TGX 4-20% 
SDS/PAGE 1D gel in TGS buffer (Tris 0.025M, Glycine 0.192M, w/v SDS 0.1%, 
200 V, 180 mA, 35 min) stained with Coomassie Blue or ProteoSilver
TM
 silver stain 
and imaged and processed. 
 
6.5.2 Protein identification  
Detected protein bands were reduced with 10 mM DTT, 0.2% EDTA in 100 mM 
ammonium bicarbonate in acetonitrile (AbC) at 56 °C for 30 min followed by 
alkalation with 50 mM iodoacetamide in 100 mM AbC in the dark at room 
temperature for 30 min. After washing the mixture was digested in trypsin buffer (13 
ng/µL trypsin in 50 mM AbC) at 37 °C for 12 h. The digested mixture was analyzed 
by LC-MS/MS (Dionic Ultimate 3000; Solvent A: 98% H2O, 2% acetonitrile (ACN), 
0.1% formic acid (FA); Solvent B: 80% ACN, 20% H2O, 0.1% FA; 100 % A to 




100% B in 1 h; MS/MS: Bruker HCT Ultra PTM). The data were analyzed with 
DataAnalysis v.4.0 SP4, BioTools 3.2 SR1 and compared with a protein database 
(Mascot version 2.2.07).    
 
6.5.3 Surfactant binding assay** 
To mimic the surfactant binding to inhaled particles and digestion of any attached 
protein corona (while inside the phagolysosome) a surfactant binding/digestion assay 
was performed. Briefly, polymeric particles at 100 cm
2
/mL were suspended in non-
diluted lung lining fluid (LLF). After 1 min of incubation, the supernatant from 
particle suspensions were collected by three rounds of centrifugation at 15000  g for 
20 min. As benchmark particles, NiO and Co3O4 nanoparticles were tested at the 
same surface area dose. The concentrations of phospholipids were measured using a 
phospholipid assay kit (Bioassay systems). The adsorbed phospholipid levels were 
calculated by subtracting the levels of LLF from those of particle supernatants. After 
washing the unbound LLF from the particle suspensions, particles were re-suspended 
with the same volume of saline and phospholipase A2 (PLA2) was applied overnight. 
The undigested phospholipid levels were measured in the particle suspensions using 
the phospholipids assay kit (Bioassay systems, CA, USA). After colour development, 
the optical density at 570 nm of the particle-free supernatant was measured.  
 
                                                          
**
 Digestion assays were carried out by Dr Wan-Seob Cho at the Centre for Inflammation Research, 
University of Edinburgh, Edinburgh. 




6.6 Cell culture 
6.6.1 General cell culture 
Human embryonic kidney cells (HEK293T) and human cervical cancer cells 
(HeLa) were cultured in Dulbecco’s modified eagle medium (DMEM) supplemented 
with 10% (v/v) heat inactivated fetal bovine serum, L-glutamine (4 mM) and 
antibiotics (100 units/mL penicillin and 100 units/L streptomycin) at 37 °C and 5% 
CO2. Cells were cultured in T-75 flasks (Nunc) until 80% confluency followed by 
removal of  growth medium, washing with PBS (10 mL) and harvesting by 
trypsination (trypsin/EDTA, Gibco) (1 mL) at 37 ºC. Detached cells were collected 
in fresh growth media and an aliquot was reseeded to a flask for re-growth. Cell 
densities were determined with a Neubauer chamber. An aliquot (10 µL) of cells was 
pipetted into the Neubauer chamber and the number of cells counted. Cell 
experiments were carried out with cells passaged between 4- and 20-times. 
 
6.6.2 Particle incubation and subsequent cell analysis 
HEK293T and HeLa were plated in DMEM, supplemented with 10% (v / v) heat 
inactivated fetal bovine serum, L-glutamine (4 mM) and antibiotics (100 units/mL 
penicillin and 100 units/L streptomycin) in a 24-well plate at a density of 20,000 
cells per well and grown for 24 h at 37 °C and 5% CO2. Thereafter, particles (12.5 
µg/mL – 75 µg/mL, Table 6.10) were added and incubated with the cells for 24 h. 
Cells were washed with PBS (2  350 µL) and incubated for a further 12 h in 
DMEM (350 µL). After incubation, cells were washed with PBS, harvested with 
trypsin/EDTA and analyzed by flow cytometry or imaged under a Leica DM IRB 
fluorescence microscope (40a, 41, 51 concentrations: Table 6.10). Quantitative flow 








To perform cellular uptake of particles 40b, 43b and 71 – 74, HEK293T and HeLa 
were plated in DMEM, supplemented with 10% (v / v) heat inactivated fetal bovine serum, 
L-glutamine (4 mM) and antibiotics (100 units/mL penicillin and 100 units/L streptomycin) 
in a 24-well plate at a density of 20,000 cells per well and grown for 24 h at 37 °C and 5% 
CO2. Thereafter, particles (12.5 µg/mL – 75 µg/mL, Table 6.10) were added and incubated 
with the cells for 2 h. Cells were washed with PBS (2  350 µL) and analyzed by flow 
cytometry. Quantitative flow cytometric analysis was carried out in triplicate and by addition 




Table 6.10. Particle incubation in HEK293T and HeLa cells. 
Particles Studied concentrations 
40a and 41 12.5, 25, 50 µg/mL 
51 12.5, 25, 37.5, 50, 62.5, 75 µg/mL 
61 and 62 12.5, 25, 50 µg/mL 
40b and 64 – 70 50 µg/mL 
40b, 43b and 71 – 74 50 µg/mL 
  
6.6.3 Cell viability 
HEK293T and HeLa were plated in DMEM, supplemented with 10% (v/v) heat 
inactivated fetal bovine serum, L-glutamine (4 mM) and antibiotics (100 units/mL 
penicillin and 100 units/mL streptomycin) in a 96-well plate at a density of 5,000 
cells per well and grown for 24 h at 37 °C and 5% CO2. Thereafter, particles (12.5 
µg/mL – 75 µg/mL) were added and incubated with the cells for 24 h. Cells were 




washed with PBS (2  350 µL) and incubated for a further 24 h in DMEM (350 µL). 
After incubation, cells were washed with PBS and incubated in 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (7 mg MTT 
in 7 mL PBS and 3 mL phenol red free DMEM) for 3 h at 37 °C. Afterwards, 100 µL 
solubilisation solution (10% triton-X 100 in acidic isopropanol (0.1 M HCl)) was 
added and the absorbance at 570 nm measured (Benchmark Biorad microplate 
reader) and results compared to untreated cells.    
 
6.6.4 Cell staining 
Sterilised cover slips (24 mm) were coated with 0.01% poly-lysine in water for 10 
minutes at room temperature then washed with PBS (6 ×). The cover slips were 
placed in 6-well plates and seeded with 90,000 treated cells/well in 1.6 mL 
Dulbecco’s modified eagle medium (DMEM) and incubated overnight. The media 
was removed and replaced with particles 61 or 62 (12.5, 25 and 50 µg/mL) in 
DMEM for 24 h. Cells were washed with PBS (2  350 µL) and incubated for a 
further 12 h in DMEM (350 µL). The media was removed and the nuclei were 
stained by incubation of the cells with a 10 µM solution of Hoechst 33342 in media 
(DMEM) for 5 minutes at 37 °C and 5% CO2. The cells were washed with PBS (2 ×) 
and the cytosol was subsequently stained with a 6 µM solution of CellTracker™ Red 
CMTPX in serum free media (Opti-MEM
TM
) for 50 min at 37 °C and 5% CO2. The 
cells were washed with PBS (2 ×) fixed with 4% formaldehyde in PBS for 30 min at 
room temperature, washed again with PBS (2 ×). Cells were imaged using a Leica 
SP5 Confocal. Microscope lasers setting were: excitation laser lines at 404 nm, 488 
nm, 595 and 633 nm with emission filters of 414-483 nm for Hoechst 33342 (nuclei 




stain), 497-586 nm for released fluorescein, 600-628 nm for CellTracker™ Red 
(cytosol stain), 642-750 nm for Cy5 (particles). 
 
6.6.5 Haemolysis assay†† 
Hemolysis Assy. Erythrocytes were obtained from fresh human venous blood, 
drawn from healthy volunteer donors with informed oral consent, under the full 
institutional ethical approval of the University of Edinburgh. The preparation of 
erythrocytes and hemolysis assay was conducted according to the previously 
described method.
229
 Surface functionalised polymeric particles (4a, 8 – 10, 12, 15, 
16 and 63) were tested at a surface area dose of 30, 100, and 300 cm
2
/mL and saline 
and 0.1% Triton X-100 was used as negative and positive controls, respectively. The 
percentage of hemolysis was calculated compared to complete hemolysis (Triton X-
100).  
Influence of the protein corona on hemolytic activity. To evaluate the impact of 
the protein corona following the particle’s residence in phagolysosomes, particles 
(4a, 8 – 10, 12, 15, 16 and 63) were incubated with 5% FBS or 10% LLF for 1 min 
and washed with saline (3 ) by the method described above. Afterwards, the 
particles were incubated with phospholipase A2 (1 U/mL) at 37 °C for 24 h followed 
by a saline wash (3 ) and incubation with proteinase K (30 mAU/mL) at 37 °C for 
24 h. The enzymatic digestion was stopped by addition of EDTA (2 mM) followed 
by a saline wash (3 ) and resuspension in saline and determining the hemolytic 
activity of the particles.  
 
                                                          
††
 Haemolysis assays were carried out by Dr Wan-Seob Cho at the Centre for Inflammation Research, 
University of Edinburgh, Edinburgh. 
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